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Abstract of the Dissertation 
The mammalian Ajuba LIM proteins (Ajuba, LIMD1, WTIP) are cytosolic adapter 
proteins recruited to nascent epithelial adherens junctions, where they are thought to 
contribute to junctional assembly and/or stability.  They also shuttle into the nucleus 
acting as corepressors of the Snail family of transcriptional repressors, thereby 
contributing to epithelial mesenchymal transition. As such they have the potential to 
communicate cell adhesive events with nuclear responses to remodel epithelia.  
Determining their role(s) in vivo, however, has been challenging due to shared interacting 
proteins, overlapping tissue expression and functional redundancy in cells. Thus, we 
turned to the Drosophila model system where a single gene, CG11063 or djub, exists. 
The generation and analysis of Drosophila containing djub mutant loss-of-function 
alleles or depleted of dJub by RNAi identify djub as an essential gene required for normal 
development and a novel regulator of epithelial organ growth as a component of the 
conserved Hippo pathway, which has been implicated in both tissue size control and 
cancer development. djub-deficient epithelial tissues were small due to decreased cell 
numbers resulting from increased apoptosis and decreased proliferation due to the 
downregulation of DIAP1 and cyclin E, phenocopying tissues deficient for Yorkie (Yki), 
the downstream target of the Hippo pathway. djub genetically interacts with the Hippo 
pathway, and genetic epistasis suggests that djub influences wts activity. In mammalian 
and Drosophila cells, Ajuba LIM proteins/dJub specifically interact with LATS/Wts and 
WW45/Sav to inhibit phosphorylation of YAP/Yki. This work describes a novel role for 



























Growth Control and the Hippo Pathway 
 
How animals, organs and tissue know when to stop growing is an unanswered 
question. Each organ in an animal has a specific architecture and pattern, and develops to 
a defined final size in proportion with the rest of the animal (Dong, Feldmann et al. 2007; 
Harvey and Tapon 2007; Saucedo and Edgar 2007). Several examples exist of 
experimental systems to dissect organ size control, one such being the regeneration of 
tissue after tissue injury or experimental procedures. For instance, after partial 
hepatectomy, the hepatocytes in the liver mobilize to proliferate rapidly and thereby 
increase the size of the regenerating liver. Once the liver reaches the original 
predetermined size, the cells stop dividing ensuring that the regenerating liver is not over-
grown (Fausto, Campbell et al. 2006).  The myth of Prometheus suggests Greeks were 
aware of the regeneration capabilities and growth regulating abilities of the liver.  
As in the case of the regenerating liver, the development of a functional organ 
requires both regulated patterning mechanisms that allow its constituent cells to acquire 
proper identities, and growth-regulatory mechanisms that determine final organ size. 
Over the past two decades, developmental geneticists have identified most of the key 
signaling pathways that regulate cell fate decisions. Such as, Notch, Wnt, TGF-β, 
Hedgehog, receptor tyrosine kinase, nuclear receptor, and Jak/STAT pathways (Barolo 
and Posakony 2002).  More recently, genetic approaches have identified two signaling 
cascades that govern organ growth. One is the tuberous sclerosis tumor suppressor 
complex (TSC)–target of the rapamycin (TOR) pathway. This pathway controls organ 
size by regulating cell growth and size (Pan, Dong et al. 2004). The other is the Hippo 
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(Hpo) pathway, which controls organ size by regulating cell growth, proliferation, and 
apoptosis. 
Genetic studies in Drosophila have been at the forefront of the identification of 
the pathways that control organ size. The Drosophila imaginal discs (small sacs of cells 
within Drosophila larvae that give rise to the adult structures of the adult fly) provide an 
ideal system to study growth control. Imaginal discs are first set aside during late 
embryogenesis after which they proliferate exponentially during the larval stages, thereby 
increasing their mass almost one-thousand fold. During metamorphosis they differentiate 
into their respective adult structures like the eye, wing or leg (Cohen 1993).  A key 
advance that enabled identification of genes that govern growth control in flies was the 
application of FRT/FLP- based site recombination events towards the ability to generate 
mosaics. This is especially relevant for genes that regulate growth control as animals that 
lack the function of one such gene die early in embryogenesis preventing the analysis of 
imagnial disc development. Thus, the generation of small patches of cells homozygous 
mutant for these genes in a heterozygous background in an imaginal disc was essential to 
be able to follow the effect of these genes on growth control (Figure 1).  
In the past fifteen years, many groups have carried out genetic screens in 
Drosophila to identify mutants that specifically affect growth and not patterning (St 
Johnston 2002).  Through these screens the first three members, hippo (hpo), salvador 
(Sav), and warts (wts), that later came to be known as the Hippo pathway were identified 
due to their overgrowth phenotype. Warts (also known as lats) was one of the very first 
genes isolated using the FLP/FRT based mosaic screen (Figure 1). Wts is a tumor 
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suppressor, and encodes a kinase of the Nuclear Dbf-2-related (NDR) family (Xu and 
Rubin 1993; Justice, Zilian et al. 1995). Loss of wts leads to severe cell-autonomous 
overgrowth in epithelial structures, but has no affect on cell fate determination.  Next, the 
binding partner of wts, salvador (sav or shar-pei), was identified (Figure 3A). This tumor 
suppressor gene encodes a WW domain-containing protein and mutations in sav lead to 
cell-autonomous overgrowth as well (Kango-Singh, Nolo et al. 2002; Tapon, Harvey et 
al. 2002). Importantly, it was found that loss of wts or sav coordinately regulates both the 
increase in cell proliferation and a reduction in apoptosis. Future experiments revealed 
that the increase in proliferation and decrease in apoptosis is brought about by the 
misregulation of the pathway’s downstream transcriptional targets CyclinE, Drosophila 
inhibitor of apoptosis protein DIAP1 respectively (Nolo, Morrison et al. 2006; Willecke, 
Hamaratoglu et al. 2006).  
The hpo tumor suppressor gene, which encodes a Ste-20 family protein kinase 
(Harvey, Pfleger et al. 2003; Pantalacci, Tapon et al. 2003; Udan, Kango-Singh et al. 
2003; Wu, Huang et al. 2003) and phenocopies the wts and sav loss of function 
overgrowth phenotypes (Figure 2), was the next critical member of the pathway 
identified. Interestingly, Hpo phosphorylates and activates Wts, with Sav further 
potentiating this phosphorylation reaction (Figure 3A) (Wu, Huang et al. 2003). Another 
NDR family regulatory protein, Mob1-related protein, termed Mats in Drosophila, was 
isolated as a binding partner of Wts, and found to potentiate the intrinsic kinase activity 
of Wts (Lai, Wei et al. 2005).  Mutations in mats yield loss of function phenotypes 
essentially identical to those observed for hpo, sav and wts. Thus, within the Hippo 
pathway kinase cascade the Hpo and Wts kinases both associate with and are stimulated 
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by regulatory proteins, Sav and Mats, respectively. In total, the Hpo kinase cascade 
inhibits proliferation by downregulating CyclinE levels, and promotes cell death by 
downregulating DIAP1 levels. The Hippo pathway mediates its effects on CycE and 
DIAP1 via its negative effect on the function of the transcriptional coactivator Yorkie 
(yki). Yki is the critical substrate and directly inhibited by the kinase activity of Wts 
(Huang, Wu et al. 2005). Wts phosphorylates Yki on residue S168, which inactivates Yki 
by promoting its cytoplasmic retention through an interaction with 14-3-3 binding 
proteins (Huang, Wu et al. 2005; Dong, Feldmann et al. 2007).  Overexpression of Yki 
phenocopies the wts loss of function phenotype with respect to both the morphological 
overgrowth phenotypes and the downregulation of diap1 and cyclinE transcription. In 
contrast, yki loss of function leads to tissue atrophy (Figure 3).   
Diap1 and cyclinE are two of the target genes regulated by Yki/Hippo pathway 
with additional targets being identified recently. The microRNA bantam, is a positive 
regulator of imaginal disc growth that regulates both cell proliferation as well as 
apoptosis, (Brennecke, Hipfner et al. 2003) is one of these as the levels of bantam 
increase in tissue overexpressing Yki (Nolo, Morrison et al. 2006). Bantam binds the IAP 
inhibitor head involution defective (hid) as one of its targets, (Brennecke, Hipfner et al. 
2003) however loss of bantam only partially reverts the yki overgrowth phenotype 
suggesting that the overgrowth phenotype results from a combination of other Yki targets 
such as DIAP1, CyclinE and others.  
Yki is a transcriptional coactivator. Thus, Yki-interacting transcription factors 
must provide Yki with its promoter selectivity. Scalloped (Sd), a TEAD-domain 
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containing transcription factor, has been reported to mediate Yki-induced gene 
expression as well as the overgrowth phenotype. Sd is a crucial regulator of cell 
proliferation and survival in wing imaginal disc cells (Halder, Polaczyk et al. 1998; 
Goulev, Fauny et al. 2008; Wu, Liu et al. 2008). Although Yki and the Hippo pathway 
function ubiquitously throughout the Drosophila tissue, Sd is expressed in narrower 
spectrum of cells (Campbell, Inamdar et al. 1992). Also yki mutants have a much more 
severe growth defect as compared to sd mutant clones and in fact Yki mutants that are 
unable to bind Sd still induce an overgrowth defect (Huang, Wu et al. 2005; Wu, Liu et 
al. 2008; Zhao, Ye et al. 2008). This suggests that other transcription factors exist that 
mediates the function of Yki and the Hippo pathway in tissues other than the wing and/or 
in a partially redundant manner with Sd. 
Upstream signaling to the Hippo pathway 
Merlin (Mer) and its related protein Expanded (Ex) have been identified as 
potential upstream regulators of Hpo (Figure 3A). Both Mer and Ex are FERM, 4.1, 
Ezrin, Radixin, Moesin, domain containing proteins. This family of proteins typically 
function as adapter proteins that link transmembrane proteins to the cytoskeleton or to 
cytoskeleton-associated proteins (Hamaratoglu, Willecke et al. 2006). Mer has a human 
ortholog, neurofibromatosis 2 (NF2), a tumor suppressor gene that has been found to be 
mutated in central nervous system tumors (McClatchey and Giovannini 2005).  Both Mer 
and Ex localize adherens junctions Drosophila.  Furthermore, Mer and Ex also 
heterodimerize with each other and seem to function redundantly to promote signaling 
through the Hippo pathway to inhibit yki function, as tissue doubly mutant for ex and mer 
yield overgrowth phenotypes that are virtually indistinguishable from hpo, wts or sav 
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mutant tissue based on morphology and molecular criteria (McCartney, Kulikauskas et al. 
2000). Genetic epistasis tests place mer and ex upstream of hpo, with the overexpression 
of Mer and Ex leading to an increase in Wts phosphorylation and a downregulation of 
Yki activity (Willecke, Hamaratoglu et al. 2006; Feng and Irvine 2007).  How Mer and 
Ex activate the Hippo kinase cascade is still unknown since neither bind Hpo directly 
(Hamaratoglu, Willecke et al. 2006).  
Most of the Hippo pathway components in Drosophila are ubiquitously expressed 
throughout imaginal disc development. The pathway may be regulated by a specific 
signal given out in a spatial or temporal fashion, triggering cell death or cell cycle exit at 
the appropriate time during development. Another view with respect to the mode of 
regulation of the Hippo pathway is that the pathway is typically constitutively active 
however its signaling capacity is modulated by other pathways. Data suggest that such 
cues may come from morphogens such as Decapentaplegic (DPP) and wingless or other 
growth regulatory pathways such as JAK-STAT (Janus kinase -signal transducer and 
activator of transcription), epidermal growth factor receptor (EGFR) and Delta-Notch 
(Hariharan and Bilder 2006). For instance, membrane proteins such as EGF receptor, 
Notch, E-cadherin and the Hedgehog receptor Patched, are found to be upregulated in the 
mer;ex double mutants suggesting that transmembrane receptor signaling is altered in 
these cells (Maitra, Kulikauskas et al. 2006).  Mer and Ex might therefore regulate the 
activity of the Hippo pathway by regulating the abundance of some of these receptor 
proteins at cell surfaces.  
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The transmembrane protein Fat (Ft), an atypical cadherin, may be the upstream 
receptor that activates the Hippo pathway (Bennett and Harvey 2006; Silva, Tsatskis et 
al. 2006; Willecke, Hamaratoglu et al. 2006). Ft is a tumor suppressor gene that acts 
linearly upstream of Ex and Hpo (Figure 3A). Ft mutant cells have a phenotype similar to 
that of hpo or wts, including the upregulation of cycE and diap1 along with increased cell 
proliferation and decreased cell death. Fat has been shown to regulate Hippo pathway 
activity by promoting the stability and/or localization of Ex to the apical membranes of 
cells (Bennett and Harvey 2006; Silva, Tsatskis et al. 2006; Willecke, Hamaratoglu et al. 
2006). The regulation of Ex is crucial since its expression is in fact stimulated when the 
Hippo pathway activity drops via a negative feedback loop.  In fact both Ex and Mer are 
upregulated in clones lacking Hippo pathway genes, hpo, sav and wts. The upregulation 
is a result of derepressed tanscription, since the levels of ex transcripts is elevated in the 
mutant clones. Ex and Mer were both found in higher levels in hpo, sav and wts mutant 
clones. This regulation is independent of the development al stage of the tissue or the 
position of the clone. Thus, the expression of the Hippo signaling pathway components 
regulates itself via the feedback loop. The regulation of mer and ex expression levels by 
Hippo signaling suggests that feedback mechanism might be an important system in place 
to keep Hippo signaling in a steady state.  
Ft is capable of regulating the Hippo pathway independent of Ex and Hpo in a 
parallel pathway. ft mutant clones show decreased Wts protein levels. Ft controls the 
abundance of the Wts protein by negatively regulating Dachs, an unconventional myosin 
(Cho, Feng et al. 2006). Dachs directly binds Wts acting as a scaffold to bring Wts to 
proteins that will promote Wts proteolysis. Both Fat and Dachs localize to apical cell 
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junctions, however so far no direct interaction between them has been established. 
Furthermore, the overexpression of Wts can rescue ft mutants to viability (Cho, Feng et 
al. 2006; Mao, Rauskolb et al. 2006; Feng and Irvine 2007). Thus the Ft-Dachs and the 
Hpo-Sav pathways act in parallel to control the levels of Wts or the activity of Wts 
respectively.  
In summary, the Drosophila Hippo pathway model as it stands now involves a 
series of events that leads to the activation of the Hippo pathway that leads to 
phosphorylation of Warts, phosphorylating Yki. This phosphorylation of Yki on Ser168 
in turn introduces a 14-3-3 binding site sequestering Yki in the cytoplasm. In its 
unphosphorylated state, Yki is not inhibited by the Hippo pathway and can bind to the 
cofactor Scalloped (Sd) and enter the nucleus where it is able to induce the transcription 
of genes, CyclinE and DIAP1, required to promote cell growth and inhibit apoptosis. 
Finally, Ex, Merlin and Fat can activate the Hippo pathway and the activation of the 
Hippo pathway can also be affected by Dachs, which binds to Wts and promotes its 
degradation (Figure 3A).  
Hippo signaling in mammals 
The Hippo pathway is highly conserved throughout evolution and the function of 
the fly proteins and their mammalian counterparts are conserved as well. Mst1/2 are the 
mammalian homologs of Hpo, WW45 the homolog of Sav, Lats1/2 are the mammalian 
homologs of Wts, Mob1 is Mats homolog, YAP is the Yki homolog, NF2 the Mer 
homolog and to lesser extent FRMD6 is the mammalian homolog of Ex homolog and 
Fat4 the Fat homolog (Figure 3B). Expression of the mammalian proteins in several of 
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the loss of function mutant flies have been rescued with their respective human 
counterparts; namely YAP, Lats1, Mst1, and Mob1 in flies mutant for the orthologous fly 
gene (Tao, Zhang et al. 1999; Wu, Huang et al. 2003; Lai, Wei et al. 2005). The strong 
rescue of the mutant phenotype indicates that these proteins are functionally conserved 
from Drosophila to mammals. The Hippo pathway function is conserved in mammalian 
cells or models with respect to organ size control since the overexpression of YAP in a 
mouse liver results in a striking increase in liver size and leads to tumor metastasis 
(Camargo, Gokhale et al. 2007; Dong, Feldmann et al. 2007). 
The conservation of the pathway for the upstream components Fat and Ex is less 
clear in mammalian cells. However, similarlar to Hpo in Drosophila, Mst is crucial in the 
mammalian Hippo pathway and functions to phophorylate the core components of the 
pathway. Mst1/2 phosphorylates Lats1/2 on its activation loop and in addition, Lats is 
capable of autophosphorylation (Chan, Nousiainen et al. 2005). Further, WW45 interacts 
with Mst, following which Mst phosphorylates WW45 (Callus, Verhagen et al. 2006). 
Mst1/2 also phosphorylates Mob1 which in turn strengthens the Mst-Lats interaction 
(Praskova, Xia et al. 2008). Similar to their Drosophila counterparts, Mst, WW45, Lats 
and Mob induce the phosphorylation, cytoplasmic translocation and inhibition of YAP 
(Overholtzer, Zhang et al. 2006; Zhang, Smolen et al. 2008). Also TEAD family 
transcription factors which are mammalian homologs of Drosophila Sd have been found 
to mediate YAP function in mammalian cells (Zhao, Ye et al. 2008). In fact, Lats directly 
phosphorylats YAP on serine residues in five conserved motifs, one of them being S127 
(Hao, Chun et al. 2008). As in the case of Yki, the S127 phsophoryaltion on YAP by Lats 
generates a 14-3-3 binding site which sequesters YAP in the cytoplasm leading to its 
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nucleus to cytoplasm translocation (Figure 3) (Lee, Kim et al. 2008). In fact using mutant 
S168 YkiA or S127A YAP transgenes in Drosophila, where the serine residues are 
changed to Alanine and cannot be phosphorylated, leads to overgrowth. This function of 
YAP being negatively regulated by the Hippo pathway is evolutionarily conserved since 
YAP’s role in promoting cell proliferation and oncogenic transformation are both 
inhibited by co-expressing Lats1 and Mst1(Zhang, Smolen et al. 2008).  
 
Hippo pathway and cancer 
The inactivation of the Hippo pathway promotes growth by promoting cell 
proliferation and inhibiting cell death, and thus may lead to cancer. In addition, several of 
the Drosophila Hippo pathway mammalian homologs have been implicated in 
tumorigenesis. The mammalian homolog of Hpo, Mst1/2, is known to be proapoptotic in 
cultured mammalian cells, (Cheung, Ajiro et al. 2003, Lehtinen, Yuan et al. 2006). Mice 
lacking the wts mammalian homolog lats, develop soft-tissue sarcomas and ovarian 
tumors (St John, Tao et al. 1999).  Lats has also been implicated in the control of mitosis 
and cytokinesis in mammalian cells, and its loss can lead to multinucleation, centrosome 
amplification and genomic instability (McPherson, Tamblyn et al. 2004). Also, Lats1 and 
Lats2 have been found to have methylation dependant silencing that correlate with the 
aggressive phenotype in human breast cancers (Takahashi, Miyoshi et al. 2005) and Lats2 
can be regulated by microRNAs miR-371 and miR-373 which are upregulated in 
testicular cancer lines and tumor samples (Aylon, Michael et al. 2006; Voorhoeve, le 
Sage et al. 2006). Therefore, the downregulation of Lats via several different mechanisms 
may promote tumor formation. WW45, the human orthologs of sav is deleted in several 
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renal cancel cell lines and in fact the WW45 knockout mouse displays hyperplasia and 
differentiation defects in mouse epithelial structures (Lee, Kim et al. 2008). MOB1K1B 
(mats) has been found to be deleted in cell lines derived from human melanoma samples 
and mouse mammary gland carcinomas (Tapon, Harvey et al. 2002; Lai, Wei et al. 2005). 
NF2 or mer is a known tumor suppressor gene mutations in which can lead to 
neurofibromatosis. Mutations in NF2 have been observed in sporadic tumors of the 
nervous system as well as other tumors like mesothelioma (McClatchey and Giovannini 
2005). Recently YAP (Yki) has been implicated in mammalian cancers. The amplicon 
11q22 in humans contains both YAP and cIAP2 and has been found to be amplified in 
several human cancers including liver, lung, pancreatic, ovarian and oesphageal (Imoto, 
Yang et al. 2001; Dai, Zhu et al. 2003; Snijders, Schmidt et al. 2005). Besides the 
genomic amplification, YAP expression and its nuclear localization has also been 
reported to be elevated in multiple types of human cancers (Zender, Spector et al. 2006; 
Steinhardt, Gayyed et al. 2008).  Also Yap when overexpressed is able to transform 
immortalized mammary epithelial cells in vitro including the ability to induce growth-
factor and anchorage-independent growth, epithelial-mesynchymal transition and 
resistance to apoptosis (Dai, Zhu et al. 2003; Overholtzer, Zhang et al. 2006). Thus, both 
yki and Yap act as oncogenes.  
 
LIM domain containing proteins 
 As a result of the studies conducted in this thesis, we have discovered a novel 
regulator of the Hippo pathway, namely the Ajuba subfamily of LIM proteins. The Ajuba 
LIM proteins are a subgroup of a larger group of LIM domain containing proteins that are 
known for their ability to carry out protein-protein interactions. LIM domains were 
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originally identified as novel cysteine-rich protein motifs, common to the Caenorhabditis 
elegans cell-lineage protein LIN-11, the rat insulin gene-enhancer-binding protein Isl1, 
and C. elegans neuronal specification gene MEC-3 (Freyd, Kim et al. 1990; Karlsson, 
Thor et al. 1990). LIM domains are protein-protein interaction domains that act as key 
components of the regulatory machinery in a cell. These domains enable LIM proteins to 
recruit specific target proteins via protein-protein interactions to specific subcellular 
compartments, modulate the activity of their targets or help nucleate the assembly of 
multi-component complexes.  Thus, through the specific binding of their targets LIM 
domain proteins are able to regulate a diverse array of cellular circuits.  
Although LIM domains are absent in prokaryotes, they are found in almost every 
eukaryotic organism whose genome has been sequenced, such as yeast, slime moulds and 
plants to Drosophila and humans. In the human genome, 135 LIM domains have been 
identified within 58 proteins (Hobert and Westphal 2000). A LIM domain contains 2 
tandem zinc-finger motifs, and LIM proteins can contain up to 5 LIM domains. Each 
LIM domain typically consists of approximately 55 amino acids. The LIM consensus 
sequence is CX2CX16–23HX2CX2CX2CX16–21CX2(C/H/D) (Schmeichel and Beckerle 
1994), however the consensus sequence becomes more variable between species and also 
within the array of LIM sequences (Michelsen, Schmeichel et al. 1993).   
 LIM domains can be linked to many different proteins domains within LIM-
containing proteins such as, SH or PDZ domains, homeodomains, catalytic domains, 
cytoskeletal-binding domains etc and finally the LIM domains can be C-terminus, N-
terminus or internal. Structural studies have made it clear that the LIM domains are 
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multiple protein binding adapters and several can use their additional motifs to mediate 
interactions with a variety of proteins, both sequentially as well as at the time with 
multiple proteins (Kadrmas and Beckerle 2004). The LIM domains can form dimers with 
other LIM domains or bind structurally varied protein motifs. LIM domain containing 
proteins are found in the nucleus as well as in the cytoplasm. The proteins are broadly 
categorized into actin associated LIM proteins, nuclear LIM proteins, LIM only proteins, 
and catalytic LIM proteins (Kadrmas and Beckerle 2004).  
The actin associated LIM proteins like the members of the zyxin, paxillin and 
enigma proteins are able to shuttle between the cytoplasmic and nuclear compartments 
therefore influencing gene expression (Breen, Agulnick et al. 1998). This group of LIM 
proteins interact with a wide variety of partners. These proteins also contain various other 
protein-protein interaction motifs such as PDZ, LD (leucine-aspartate repeat) and actin 
target domains (Figure 4). Several of these proteins localize to focal adhesions (Zyxin, 
Paxillin).  Extracellular signals induce the translocation of these proteins into the nucleus 
potentiating the transcriptional regulation of target genes. Once in the nucleus these 
proteins also act as transcriptional co-activators and co-repressors (Wang and Gilmore 
2003). The Ajuba subfamily of proteins are members of this group and will be the focus 
of the thesis in the following chapters. 
Nuclear proteins like the LIM homeodomain proteins (LHX) and nuclear LIM 
only proteins (LMO) contain N terminal tandem LIM domains and are primarily involved 
in transcription during development (Figure 4) (Hobert and Westphal 2000). The LHX 
and LMO proteins also play a role in cell lineage determination and pattern formation 
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during development (Breen, Agulnick et al. 1998). The LMO proteins are transcriptional 
co-factors and form complexes with other transcription factors in order to regulate 
transcription. LHX proteins however are transcription factors that bind DNA through 
their homeodomain. (Jurata and Gill 1997; Matthews and Visvader 2003; Deane, Ryan et 
al. 2004).  
 The LIM only proteins include four-and-a-half LIM (FHL), cysteine rich proteins 
(CRP) and particularly interesting new cystein- and histidine-rich proteins (PINCH) as 
well as some nuclear LMOs (Figure 4). These are found both in the nucleus as well the 
cytoplasm and both associate with the cytoskeleton (Weiskirchen and Gunther 2003). 
FHL2 and FHL3 are examples of proteins that are components of the adhesion complexes 
(Li, Kotaka et al. 2001; Samson, Smyth et al. 2004).  
The third group, the catalytic LIM protein group is similar to the actin-associated 
group with respect to containing other protein-protein interaction motifs but this group 
contains the mono-oxygenase or kinase catalytic motif (Figure 4), which distinguishes 
them from the other LIM proteins (Kadrmas and Beckerle 2004). This group includes 
LIM-kinases and molecules interacting with CasL (MICALs), which are involved in cell 
cycle regulation and actin polymerization and depolymerization.  
Ajuba/Zyxin family of LIM proteins 
The Ajuba/Zyxin families of LIM proteins are actin binding proteins, and consist 
of six members: Zyxin family; Zyxin, lipoma preferred partner (LPP), thyroid hormone 
interacting protein 6 (Trip6), and Ajuba family; Ajuba, LIM domain-containing protein 1 
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(LIMD1), Wilms tumor 1 interacting protein (WTIP) (Figure 5) (Crawford, Michelsen et 
al. 1992; Petit, Mols et al. 1996; Beckerle 1997; Goyal, Lin et al. 1999; Kiss, Kedra et al. 
1999; Wang and Gilmore 2003). These proteins are characterized by the presence of three 
tandem homologous LIM domains in the carboxyl terminus (LIM region) and unique 
proline-rich N-terminal PreLIM regions (Figure 5) (Schmeichel KL et al., 1997). The 
proteins all share high sequence homology within the LIM domain region.  
These proteins are also components of the cell-cell junction adhesive complexes 
in epithelial cells and fibroblasts (Hoffman, L. M et al., 2003, Marie et al 2003).  As such, 
they have been shown to regulate cell migration in fibroblasts and contribute to the 
establishment and/or maintenance of cell-cell junctions in epithelial cells (Marie, H.S. et 
al., 2003 Crawford and Beckerle, 1991). In addition, these proteins are capable of 
shuttling to and from the nucleus as each one contains a nuclear export signal (NES) in 
their individual PreLIM regions (Figure 5) (Nix and Beckerle 1997; Kanungo, Pratt et al. 
2000). This characteristic renders them strong candidates to mediate signal transduction 
steps from the cell surface to the nucleus. The purpose of this thesis is to further examine 
the role of this family in signal transduction. In fact understanding how these proteins 
function at the level of junctions as well as in other compartments will shed light on the 
outside-in signaling that cells are able to orchestrate.   
Ajuba/Zyxin LIM proteins have been implicated in cell motility regulation, 
localize to focal adhesion sites, and associate with the actin cytoskeleton (Crawford, 
Michelsen et al. 1992; Petit, Fradelizi et al. 2000; Yi, Kloeker et al. 2002). Zyxin family 
members have the ability to bind α-actinin and contribute to the bundling of actin fibers. 
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Abrogating the Zyxin- α-actinin interaction displaces Zyxin from its normal subcellular 
localization and the cells show inhibited migration and spreading (Drees, Andrews et al. 
1999). The Zyxin family members, and not the Ajuba family members, are recruited to 
the leading edge of cells where they influence the actin assembly via an interaction with 
Ena/VASP proteins (Renfranz and Beckerle 2002).  
 With respect to the nuclear function of the Ajuba/Zyxin proteins, although the 
significance of Zyxin family members nuclear localization is not clear, we know that the 
accumulation of Ajuba in the nucleus plays a role in growth control and cell 
differentiation (Kanungo, Pratt et al. 2000). Overexpression of just the LIM domain 
region alone, which lacks the nuclear export sequence will accumulate in the nucleus and 
induce endodermal differentiation. Exactly how the Ajuba proteins are recruited to these 
different cellular is not well understood. As for the Zyxin family members, these proteins 
can localize to the nucleus but what their nuclear biological function and the regulation of 
their nuclear localization is not understood (Crawford and Beckerle 1991; Crawford, 
Michelsen et al. 1992; Nix and Beckerle 1997). Also both Ajuba and Zyxin have been 
implicated in mitotic cell cycle regulation. Both can associate with the tumor suppressor 
Lats1 and Ajuba can also interact with mitotic kinase Aurora A (Hirota, Morisaki et al. 
2000; Abe, Ohsugi et al. 2006).  
 The zinc finger structures in the LIM domains are known to mediate DNA 
binding in transcription factors. Evidence suggests that the Ajuba/Zyxin family members 
may not directly bind DNA but may act in the nucleus to affect transcription. These 
proteins are able to bind several nuclear proteins as well as transcription factors and have 
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been shown to have transactivation ability as measured by reporter gene assays (Lee, 
Choi et al. 1995; Petit, Fradelizi et al. 2000; Yang, Guerrero et al. 2000; Wang and 
Gilmore 2003). Based on the present data it appears that the LIM domains mediate the 
interaction with the transcription factors and the N-terminal domains act to enhance the 
transcriptions. It is also possible that the domains may act as sites for nucleation for the 
recruitment of transcription factor co-activators. 
 The Ajuba/Zyxin LIM proteins have been shown to regulate other signaling 
pathways as well. For instance, the PreLIM region consists of a putative SH3 recognition 
motif and in fact Ajuba and Zyxin interact with the SH3 domains of Grb2 and Vav 
respectively (Hobert, Schilling et al. 1996; Goyal, Lin et al. 1999). The functional 
relevance of the Zyxin-Vav interaction is unclear but the Ajuba-Grb2 interaction leads to 
an increase in Ras-dependent serum stimulated extracellular signal-regulated kinase 
(ERK) activation. The ERK acticvity in turn results in increased fibroblast proliferation 
(Goyal, Lin et al. 1999). 
 In summary, the Ajuba/Zyxin families play a robust and sometimes overlapping 
role in signal transduction within the cellular system. However, the roles of the Ajuba 
subfamily start to diverge from that of the Zyxin subfamily in epithelial systems.  
 
Cellular roles of the Ajuba subfamily of LIM proteins 
Studies have shown that Ajuba LIM proteins influence cell migration without 
impacting cell adhesion and cell spreading. In these studies, Ajuba acts upstream of focal 
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adhesion protein p130Cas localizing it to nascent adhesive sites in migrating fibroblast 
cells. The p130Cas–Crk complex leads to activation of Rac1, via an interaction with the 
DOCK180–ELMO guanine nucleotide exchange factor (GEF).  Previous studies from our 
lab have also shown that Ajuba null primary MEFs are defective in cell migration. In 
response to the migratory cues Rac activation was found to be defective in the null cells, 
in part through aberrant assembly and localization of the p130Cas–Crk–DOCK180-
ELMO Rac GEF (Pratt SJ et al., 2005). These data show that Ajuba regulates cell 
motility by activating Rac through regulating the recruitment of p130Cas to nascent 
adhesion sites.   
In experiments conducted to further understand the signal transducing role of the 
Ajuba LIM proteins, it was found that the LIM region of Ajuba interacts with the atypical 
protein kinase C (aPKC) scaffold protein, p62, to regulate IL-1 induced NF-κB activation 
by impacting the assembly and activity of the aPKC/p62/Traf6 multiprotein signaling 
complex (Feng and Longmore 2005).  
In the nucleus, the Ajuba family members were identified as interactors of the 
SNAG domain of Snail, a transcriptional repressor. Interestingly none of the Zyxin 
family members interacted with the SNAG domain. In both in vitro as well as in vivo 
studies Ajuba LIM proteins function as SNAIL co-repressors to repress the transcription 
of E-cadherin. The Ajuba LIM proteins are recruited to the endogenous E-cadherin 
promoter in a SNAIL dependent manner (Langer, Feng et al. 2008). In vivo studies 
showed that expression of the Ajuba family members is similar to the expression pattern 
of SNAIL and they cooperate with each other during neural crest development in 
 20 
Xenopus. In another study with respect to the nuclear function of Ajuba LIM proteins, it 
was found that the gene transcription regulating protein arginine methyltransferase 
(PRMT5), is a component of the SNAIL-silencing complex and does so being bound to 
Ajuba (Krause, Yang et al. 2007).  
The Ajuba subfamily of LIM proteins are most abundantly expressed in tissue 
with extensive epithelia such as skin, kidney, and lung. In primary human keratinocytes 
Ajuba LIM proteins co-localize with cadherin adhesive complexes at sites of cell-cell 
contacts. Ajuba is recruited to cadherin adhesive complexes at AJ, in response to calcium 
addition, and occurs via a direct interaction with -catenin bound to cell surface E-
cadherin. Ajuba null mice appear to be completely viable, healthy and fertile with no 
gross morphological defects. However, Ajuba null mice keratinocytes exhibit abnormal 
cell-cell junction formation and/or stability and function. The Ajuba LIM domains 
responsible for targeting Ajuba to epithelial cell junctions do so through a regulated 
interaction with -catenin (Reinhard, Zumbrunn et al. 1999; Kanungo, Pratt et al. 2000; 
Marie, Pratt et al. 2003), while the PreLIM region of Ajuba directs its interaction with 
filamentous actin (Marie et al 2003). These data suggest that Ajuba may contribute to the 
bridging of the cadherin adhesive complexes to the actin cytoskeleton (Marie H et al., 
2003).  
Although the molecular mechanism for many of these processes is not completely 
understood these data provide us with clues to the roles the Ajuba subfamily of LIM 
proteins may play within the context of cellular processes. Based on previous studies and 
the shuttling ability of the Ajuba LIM proteins, the family members make strong 
 21 
candidates for signal transduction between cell-cell junctions, the cytosol and the 
nucleus. Further investigations are necessary to determine other signaling pathways that 
are targets of the Ajuba LIM proteins and also the impact of the subcellular localization 
of the LIM proteins on their function. One issue that has not yet been overcome is the 
potential for functional redundancy between Ajuba, LIMD1 and WTIP, which would 
make it difficult to dissect their roles. This thesis will focus on creating an epithelial 
system to assay for the function of the Ajuba LIM protein subfamily as a whole. Further, 
it will establish a novel growth regulatory role for the Ajuba subfamily of LIM proteins 
















Figure 1: FLP FRT mediated clonal analysis allows the induction of mitotic 
recombination in a heterozygous (+/-) background of cell (light green) that leads to one 
homozygous mutant (-/-) daughter cell (GFP negative) and another homozygous wild-type 
(+/+) cell (GFP positive- dark green) following cell division. Ensuing rounds of cell 
proliferation of the two sister-cell populations is then assessed later in development. Cells 
that are homozygous null for a growth-promoting gene (yki or bantam) will form smaller 
clones as compared to the darker green wild type cells (top, right panel). Cells that 
become homozygous null for the mutation in a growth-restrictive gene (such as hippo or 
warts) form larger clones relative to their wild-type sisters (bottom, right panel). And if 
there is no growth defect then the GFP negative clone of cells remain comparable to the 













Figure 2: Growth control by the hippo pathway. (A-C) SEM images of adult 
Drosophila eyes the following genotypes: Wild type (A), Flies homozygous null for hpo 
displaying an overproliferation eye phenotype (B) and adult fly eye homozygous null for 
yki displaying severely reduced eye structure (C). BRDU staining in a hpo null clone 
(GFP negative cells) generated using eyeless-flp method. Increase in proliferation is 
reflected by the increase in BRDU (red) staining (D). TUNEL (red) staining in a hpo null 
clone (GFP negative cells) generated using Eyeless-flp method. There is a decrease in 
cell death (E). Overexpression of Yki in a larval wing disc (right) shows a dramatic 
increase in cell proliferation as seen by the overgrowth as compared to the wild-type 







Figure 3: The Hippo pathway in Drosophila and in mammals as elucidated by genetic 
epistasis analysis and biochemical tests. Salvador/WW45 and Mats/MOB activate the 
kinase activity of Hippo/Mst and Warts/Lats, respectively. The membrane-associated 
proteins Merlin and Expanded promote the phosphorylation and activation of Warts/Lats 
by Hippo/Mst. Once activated, Warts phosphorylates and inactivates the transcriptional 
co-activator Yorkie/Yap. The green arrows represent the Hippo pathway in its ON state 
which leads to the phosphorylation of Yki/Yap and its sequestration in the cytoplasm. 
The red arrows represents the Hippo pathway in its OFF state which would allow 









Figure 4: Classification and the domain structures of LIM domain proteins. LIM 
domain proteins are roughly classified into four groups according to the arrangement and 
position of LIM domains. The groups are: Nuclear LIM proteins, LIM only proteins, 
actin associated LIM proteins and catalytic LIM proteins. The individual LIM domains 
are shown as black boxes; other domains are shown as white boxes and indicated 
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Figure 5: Schematic diagram of the Ajuba/Zyxin family of LIM proteins. This 
subgroup of LIM proteins is characterized by three homologous C-terminal LIM domains 
and a non-homologous N-terminal PreLIM region. Phylogenetically, the family can be 
split into two subfamilies as shown, one being the Ajuba subfamily consisting of Ajuba, 
LIMD1 and WTIP and the other being the Zyxin subfamily comprising of Zyxin, LPP 
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In multicellular organisms epithelia constitute the boundary that separates the 
individual from the environment. Epithelial cells organize tissue architecture by acting as 
physiological and mechanical barriers by providing sites of exchange for ions and 
molecules (Rodriguez-Boulan and Nelson, 1989). The establishment of cell-cell adhesion 
contact sites or junctions is required for epithelia function. Once the junctions are formed, 
their integrity is preserved by the segregation and maintenance of specific proteins and 
lipids in distinct plasma membrane domains (i.e., epithelial polarity). 
The link between epithelial cells is made possible by complexes such as 
desmosomes, gap junctions, adherens junctions (AJs) and tight junctions (TJ’s) that 
together constitute the Intercellular Junctional Complex (Figure 1). The three main 
functions achieved by cell-cell junctions are: (1) adhesion, or mechanically attaching 
cells to one another, (2) communication between cells, which allows passage of chemical 
or electrical signals, and (3) establishment of epithelia apico-basal polarity. The 
junctional complexes contain transmembrane receptors, usually glycoproteins that 
mediate binding at the extracellular surface. The associated cytoplasmic proteins of these 
receptors structurally link them to the cytoskeleton. This connection helps establish 
molecular lines of communication to other cell-cell junctions and to cell-substratum 
junctions. The link between cell-cell junctions and the cytoskeleton allows single cells of 
an epithelial sheet to function as a coordinated tissue (Figure 1). Thus, intercellular 
junctions function to integrate a number of cellular processes ranging from cytoskeletal 
dynamics to proliferation, transcription, and differentiation (Kowalczyk et al. 1999 and 
Kowalczyk et al. 1999).          
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 Recent evidence has uncovered a key role for AJs not only in directing 
coordinated cellular organization and movements within epithelia, but also in conveying 
information from the environment to the interior of cells. AJs are cadherin-dependent 
adhesive structures that are intricately linked to the actin microfilament network (Figure 
1). The establishment and stability of AJs is tightly regulated and essential for processes 
such as wound healing, epithelial mesenchymal transition during normal development 
and in cancer metastasis, tissue morphogenesis and development. AJs consist of calcium 
independent (nectins) and calcium dependent (cadherins) transmembrane cell adhesion 
molecules (Perez-Moreno et al. 2003; Takai et al. 2003; Takai & Nakanishi 2003). 
Associated with the cytoplasmic tails of cadherins are the linker proteins, catenins that, in 
part, facilitate an interaction with the actin cytoskeleton. Precisely how cadherin 
engagement triggers AJ formation, epithelial polarity, and epithelial integrity is an area of 
active investigation. In addition to a structural role, AJ also generate local signals or cues 
that influence cell shape and motility (Gumbiner 1990). The activation of junctional 
complexes is thought to initiate various events such as epithelial polarization, assembly 
of other junctional components, such as desmosomes and TJs (Marrs et al 1995) and also 
initiating signaling cascades to trigger nuclear events leading to growth (proliferation via 
cell cycle genes) or cell death. Although the molecular and regulatory mechanisms are 
not fully understood, novel signaling events at AJ-cytoskeletal intersections are yet to be 
discovered. 
The Ajuba LIM proteins are most abundantly expressed in tissue with extensive 
epithelia such as skin, kidney, and lung. As compared the Zyxin family of LIM proteins, 
the Ajuba subfamily are more highly expressed in epithelial tissue as compared to 
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fribroblasts (Figure 2A). In primary human keratinocytes Ajuba co-localizes with 
cadherin adhesive complexes at sites of cell-cell contacts. Ajuba is recruited to cadherin 
adhesive complexes at AJ, in response to calcium addition (Figure 2B), and occurs via a 
direct interaction with -catenin bound to cell surface E-cadherin. Ajuba null mice 
appear to be completely viable, healthy and fertile with no gross morphological defects. 
However, Ajuba null mice keratinocytes exhibit abnormal cell-cell junction formation 
and/or stability (Figure 3) and function. The Ajuba LIM domains responsible for 
targeting Ajuba to epithelial cell junctions through a regulated interaction with -catenin  
(Marie et al., 2003), while the PreLIM region of Ajuba directs its interaction with 
filamentous actin (Marie et al 2003). These data suggest that Ajuba may contribute to the 
bridging of the cadherin adhesive complexes to the actin cytoskeleton (Marie H et al., 
2003). Although the exact role of Ajuba at cellular junctions and its downstream 
consequences are unclear, the LIM proteins may play a part in the assembly of protein 
complexes involved in processes leading up to stable junction formation between cells. 
We also know that Ajuba is recruited to cell-cell contacts at early stage of assembly of 
junctional complexes making it a good candidate for regulating the assembly of 
junctions.  Many of the structural proteins at TJs and AJs act not only as structural 
components but also as signal transducers that may be involved in junctional biogenesis. 
However the molecular mechanisms by which Ajuba may be involved in cell adhesion as 
well as cell polarity are far from clear. Here we find that the depletion of Ajuba LIM 
proteins results in disrupted cell junctions and loss of cell polarity leading to a functional 




Establishing a cell based model to investigate the role of Ajuba LIM proteins in 
epithelia.  
All previous studies regarding the epithelial role of Ajuba LIM proteins were 
done in primary keratinocytes from Ajuba null mice which although illustrative of the 
importance of Ajuba LIM proteins are not an ideal model system. The precise molecular 
mechanisms whereby Ajuba regulates junction formation and, or function are still not 
clear. The observed defects from the absence of Ajuba LIM proteins may arise from the 
inability to initiate the formation of proper junctions or the inability of Ajuba null cells to 
maintain proper junctions. To answer these questions the use of primary keratinocytes are 
not ideal owing to their inability to polarize precluding an analysis of epithelial polarity 
response and also for biochemical assays, since they do not proliferate.  
Thus to address these questions we developed a stable cell based system by 
making clones of cultured kidney epithelial cells (Madin-Darby canine kidney; MDCK) 
and mouse epithelial cells (PDV) deficient in Ajuba LIM proteins.  MDCK cells are ideal 
for imaging epithelial formation because of their ability to polarize in both 2- and 3-
dimensional culture systems and undergo nascent cell-cell junction formation in response 
to added calcium.  First we established the localization of Ajuba in PDV cells as well 
MDCK cells. Ajuba localized to the cell-cell junctions in PDV cells. In MDCK cells 
using filters we were able to distinguish the adherens junctions from the tight junctions 
and found that Ajuba specifically colocalized with E-cadherin to the adherens junctions 
(Figure 4A-B). To modulate Ajuba protein levels in PDV cells we used a lentivirus 
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system expressing shRNAs against mouse Ajuba.  This FLR lentivirus system allowed 
for controls against off-target effects of RNAi and structure-function analyses of genes of 
interest by allowing for concurrent endogenous gene product knock down and exogenous 
rescue with GFP-tagged, RNAi-resistant forms of the gene under study, in the same cell 
(Figure 5).  The presence of a puromycin selection cassette permit selection of transduced 
cells.  The lentiviral vector system provided high efficiency, stable integration, and thus, 
expression of the shRNA (Figure 5). Using this stable lentivirus system, we knocked 
down Ajuba in mouse PDVs and MDCK cells. Ajuba protein levels were reduced by 85 
%, as detected by Western blots of cell lysates from the cells infected with the lentivirus 
system (Figure 5B). Moreover, the blots also show the reintroduction of RNAi resistant 
YFP-Ajuba protein in the knocked down cells (Figure 5B). This enabled us to confirm 
that any defective phenotype from the knock down is specific to Ajuba and not an artifact 
of RNAi off-target affects. Also this knock down was specific to Ajuba as there were no 
observable change in protein levels of other junctional proteins such as PAR-3 and E-
cadherin (Figure 6B) or other Ajuba family members LIMD1 (Figure 6B), between 
knock down and control lysates. Ajuba RNAi knock-down was also confirmed by 
immunofluorescence (Figure 6A). We also used a transient transfection method with 
double stranded RNAi oligos (Ambion), to knock down Ajuba in MDCK cells (Figure 





Cells depleted for Ajuba LIM proteins display delayed nascent junction formation 
  
To manipulate the process of cell-cell junction assembly in the MDCK cells we 
used the calcium switch method (Gao et al., 2002). The experiment involves the 
withdrawal of calcium from the cell media causing the rapid loss of cell−cell adhesion 
and endocytosis of surface E-cadherins. This process is then reversed by the re-addition 
of calcium (a calcium switch), which allows for the rapid reformation of nascent 
epithelial junctions (Figure 7A-C and 8A-A’’). Removal of calcium from the media 
results in the disassociation of cell-cell junctions and the re-distribution of E-cadherin and 
Occludin. In wt and Ajuba -/- cells when calcium was removed from the media, the 
intracellular staining of E-cadherin and Occludin increased and the plasma membrane 
labeling decreased at cell-cell contacts (Figure 8A, B, C, D). As a result cells loose their 
cell-cell junctions. Following calcium addition, recruitment of Occludin and E-cadherin 
back to the cell surface takes place within two hours in wild type cells (Figure 8A-A’’), 
however this relocalization of the junctional proteins is significantly delayed in the Ajuba 
kd cells (Figure 8B- B’’ and F-F’’). These results show that the absence of Ajuba results 
in a kinetic delay of the recruitment of E-cadherin and Occludin to the lateral membrane 
during junctional complex assembly. Interestingly when we knocked down LIMD1 we 
observed a similar kinetic delay in the relocalization of Occludin and E-cadherin (Figure 
8C-C’’, G-G’’). In MDCK cells deficient for both Ajuba and LIMD1 (Figure 6C) the 
recruitment of Occludin and E-cadherin to nascent junctions was more severely affected 




Cells depleted for the LIM proteins display defective cellular morphology 
 
 
In addition to carrying out a calcium switch we also looked at the morphology of 
cells when they were knocked down for the LIM proteins. PDV cells infected with 
control virus maintained a flat monolayer of cells, while cells infected with Ajuba siRNA 
appeared to be mounded or taller than control cells (Figure 9A-B). We further were able 
to confirm this morphology defect in MDCK cells with Z-stack analysis of confocal 
images.  MDCK cells were infected with lentiviral vectors encoding Ajuba siRNA, 
resulting in a loss of about 90% of Ajuba.  The lentiviral vectors used also encoded either 
YFP alone or YFP-tagged murine Ajuba to rescue the Ajuba siRNA.  Expression of YFP-
mAjuba was also confirmed by western blot (Figure 5). Immunofluorescence was then 
performed on control, Ajuba knock down and rescue cells for E-cadherin. In MDCK cells 
with Ajuba knockdown, E-cadherin levels were not altered by knock down of Ajuba 
(Figure 9, E as compared to F, E-cadherin in red).  Z-stack analysis using confocal 
microscopy revealed that the Ajuba knockdown cells are taller and have E-cadherin 
expressed on the apical surface, suggesting a possible effect on cell polarity as well 
(Figure 9E-F).  This phenotype was rescued by the reintroduction of murine Ajuba, 
showing specificity of the siRNA (Figure 9G).  Another phenotype observed in cells 
depleted for Ajuba in MDCK cells was that the cells appeared to form projections that 
either were trying to form stable junctions with the adjacent cells or were unable to 
maintain or preserve the junctions. This was seen by nucleofecting MDCK cells with 
Ajuba and LIMD1 siRNA and comparing them to the control pool of cells nucleofected 
with LucsiRNA and then stained with E-cadherin (Figure 9 C-D).   
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Ajuba LIM proteins are necessary the normal function of epithelial cells measured 
by cell aggregate formation and functional tight junctions.  
The immunofluorescence data suggested that the Ajuba LIM proteins may play a 
role in cell-cell adhesion and junction formation. However, the calcium switch assays did 
not provide any functional assessment on the stability of the junctions in the absence of 
Ajuba LIM proteins. To determine whether the Ajuba LIM proteins affect junctional 
stability we performed the hanging drop assay (Figure 10A) that measure initial junction 
formation and the stability of formed junctions. Wild type cells formed large cell 
aggregates faster than the knock down and also acquire resistance to the trituration forces 
(strengthening of junctions) at a higher rate than the knock down cells (Figure 10B-I). 
This suggested that Ajuba contributes to cell-cell junction formation and/ or the 
stabilization of newly formed junctions.  The results indicated that Ajuba depletion 
delays or inhibits the formation of large cell clusters.  
The delay in the recruitment of Occludin to the tight junctions during calcium 
switch (by immnuofluorescence) suggested that Ajuba might play a role in the 
establishment of tight junctions. We next sought to determine if Ajuba depletion affected 
the establishment of apical-basal polarity. Although the tight junctions appear intact at 
the end of 6 hours of a calcium switch in the knockdown cells, do they function properly? 
To answer this question, we measured the pericellular permeability of control and 
knockdown cells by trans-epithelial resistance (TER) during a calcium switch at various 
time points. Tight junctions serve as a selective permeability barrier for paracellular ion 
flow and generating a resistance (the TER) between the apical and basolateral media 
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(Figure 11A). Thus, the TER measurements can be used to monitor the tightness of the 
seal between neighboring cells serving as a functional measure of tight junction integrity. 
Control and rescued Ajuba kd cells showed a rapid increase in TER after the re-addition 
of calcium, while in contrast, Ajuba kd cells exhibited a significant delay in TER 
development (Figure 11B). These results suggested that Ajuba contributes to the 
assembly of tight junctions between epithelial cells. 
 
Establishing an Ajuba family null system in epithelial cells 
 The above results confirmed that creating a family null would be critical so as to 
understand the role of this protein family. The results from Figure 8 make it clear that the 
depletion of multiple family members (phenotype of Ajuba and LIMD1 double knock 
down is worse that the two individual knockdowns) worsens the delay in nascent junction 
formation during a calcium switch. To achieve this, we next established a way to knock 
down the third Ajuba subfamily member, WTIP. This would allow us to perform 
junctional formation and maintenance assays in the absence of all three proteins to dissect 
the role of this family in epithelia. As with knocking down Ajuba in MDCK cells using 
synthetic oligos custom made by Ambion, we used the same technique to knock down 
canine WTIP.  First, we established the ability to carry out immunofluorescence against 
the WTIP antibody in MDCK cells. Like Ajuba and LIMD1, WTIP localizes to cell-cell 
junctions (Figure 12A-A’’).  Next we subjected MDCK cells to nucleofection using 
siRNA made to WTIP. For images taken with the same exposure we were successfully 
able to reduce the levels of WTIP in the cells (Figure 12B compared to A). After 
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establishing that we can knock down WTIP we next wanted carry out triple knock down 
experiments in MDCK cells to achieve a family null. We accomplished this by first 
generating a stable MDCK line depleted of Ajuba using lentiviruses expressing canine 
Ajuba shRNA, and then transiently depleting Limd1 and WTIP using RNAi oligos. The 
Ajuba and LIMD1 double null cells were viable, but when these cells were depleted of 
WTIP to generate Ajuba/LIMD1/WTIP triple depleted MDCK cells, we found significant 




















 The Ajuba family of LIM proteins, comprising of Ajuba, LIMD1 and WTIP are 
proteins that are predominantly found at cell-cell E-cadherin junctions in normal 
epithelia. Ajuba plays an important role in the formation of nascent epithelial junctions. 
In fact if the LIM proteins are depleted in epithelia, cells display a disruption of E-
cadherin staining and cell morphology is altered. A similar phenotype is observed with 
knocking down LIMD1 or WTIP.  
In this chapter, we established cell lines, namely PDV and MDCK cells, to 
circumvent the drawbacks of using primary keratinocytes for our analysis of the LIM 
proteins. The MDCK cells proved to be ideal for imaging the formation of epithelial 
sheets given their ability to polarize on filters undergo nascent cell-cell junction 
formation in response to added calcium and grow in large numbers for biochemical 
experiments.  
To assay for the role the Ajuba LIM proteins play in nascent junction formation, 
cells depleted for the LIM proteins were subject to calcium switch experiments. Removal 
of calcium from the media resulted in the disassociation of cell-cell junctions and the re-
distribution of E-cadherin and Occludin. In wt as well as in cells depleted for Ajuba, 
LIMD1 and Ajuba/LIMD1 double knock down, the intracellular staining of E-cadherin 
and Occludin increased and the plasma membrane labeling decreased at cell-cell contacts. 
However, following calcium addition, recruitment of Occludin and E-cadherin back to 
the cell surface was delayed in the Ajuba LIM protein kd cells. The immunofluorescence 
data suggested a role for Ajuba LIM proteins in cell-cell adhesion and junction formation.  
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To assay for the junctional stability of cells depleted for the Ajuba LIM proteins, 
we carried out cell-cell aggregation assays that measure initial junction formation and the 
stability of formed junctions. We found that in case of wild type cells, they formed large 
cell aggregates faster than the knock down and also acquire resistance to the trituration 
forces (strengthening of junctions) at a higher rate than the knock down cells. This 
suggested that Ajuba contributes to cell-cell junction formation and/ or the stabilization 
of newly formed junctions.  These results indicated that Ajuba depletion delays or 
inhibits the formation of large cell clusters. The delay in the recruitment of Occludin to 
the tight junctions during calcium switch (by immnuofluorescence) suggested that Ajuba 
might play a role in the establishment of tight junctions as well. So to measure the 
function of the tight junctions we measured the paracellular permeability of control and 
knockdown cells by trans-epithelial resistance (TER). TER measurements are a 
functional measure of tight junction integrity. The lowered resistance of the knock down 
cells indicates that the tightness of the seal between neighboring cells is weakened. These 
results suggested that Ajuba LIM proteins contribute to the assembly of tight junctions 
between epithelial cells.    
From all the assays carried out to understand the role of the Ajuba subfamily of 
LIM proteins, it appeared that the defect was a kinetic delay. The results shed light on a 
possible mechanism, however they also suggested that each of the family members 
compensate for any defect brought out by the depletion of the other. This was brought out 
by the analysis of cells knocked down for LIMD1 in MDCK cells in addition to Ajuba to 
look at the effect of the double knock down on cell-cell junction formation integrity. In 
MDCK cells deficient for both Ajuba and LIMD1 the recruitment of E-cadherin 
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(adherens junctions protein) and Occludin (tight junction protein) to nascent junctions 
was more severely affected than when only the individual proteins were knocked down. 
Given the possibility of functional redundancy, the next obvious direction was to create a 
family null. However although we were able to successfully knock down WTIP, we ran 
into technical difficulties with respect to the triple knock down or depletion of Ajuba, 
LIMD1 and WTIP. These cells showed extensive cell death making analysis of their 
epithelial integrity very difficult. Thus, future experiments will involve methods to 
circumvent this limitation by moving to different model system. The main issue within 
the mammalian system is the problem with redundancy of the three Ajuba LIM proteins. 
Future experiments were designed in a simpler model organism namely, Drosophila 












 To modulate Ajuba protein levels in MDCK cells we used a lentivirus system expressing 
shRNAs against canine Ajuba.  This FLR lentivirus system allows for controls against 
off-target effects of RNAi and structure-function analyses of genes of interest by 
allowing for concurrent endogenous gene product knock down and exogenous rescue 
with GFP-tagged, RNAi-resistant forms of the gene under study, in the same cell.  The 
presence of a puromycin selection cassette permits selection of transduced cells.  The 
lentiviral vector system provides high efficiency, stable integration, and thus, expression 
of the shRNA.  
Calcium Switch assay 
 To manipulate the junction assembly in the MDCK cells we used a calcium switch 
method (Gao et al., 2002). The experiment involves the withdrawal of calcium from the 
medium causing the rapid loss of cell−cell adhesion and endocytosis of surface E-
Cadherins. This process is then reversed by the re-addition of calcium (a calcium switch), 
which allows for the rapid reformation of nascent epithelial junctions. MDCK cells are 
plated on Transwell collagen filters in 1XMEM media with 1.8mM calcium (normal 
calcium medium HCM). After 40-44 hours once a confluent monolayer of cells has 
formed the cells are washed with PBS and incubated in media containing no calcium 
(LCM) for 16-18 hours. The following day the media was switched back to HCM for 
indicated times, after which cells are washed, fixed, and stained with antibodies to Ajuba, 
E-cadherin (AJ), and Occludin (TJ) and visualized via confocal microscopy (Fig 4). 
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Hanging Drop Assay 
To examine how Ajuba functions in cell-cell adhesion we used a cell aggregation assay 
called the hanging drop assay (Elbert M et al., 2006, Redfield et al., 1997). In this assay 
the cells are placed in suspension culture and allowed to aggregate for various times. The 
cells are then counted and binned into fours groups 0-5, 5-10, 11-50 or >50 cell 
aggregates. Over time cells incorporate into larger aggregates reflecting the rate of cell-
cell junction assembly or the ability of cells to form intercellular connections with one 
another. Next the cells are triturated to break weak cell-cell interactions while strong cell-
cell junctions allow cells to remain as aggregates. So the ability of the cells to remain in 
an aggregate after trituration with a micropipette tip relative to the number of cells that 
were initially in the aggregate before trituration gives the rate at which the cell-cell 
junctions are strengthened (Fig 5). 
Transepithelial Resistance Assay 
The assay requires a confluent layer of MDCK cells grown on the Transwell collagen 
filters and subject to a calcium switch. The TER is then measured using voltage and 
current clamps (EVC4000 Precision V/I Clamp, World Precision Instruments) over a 10 
hour time period (Fig 6). The same numbers of cells are plated per filter allowing the 
TER from Ajuba knocked down to be compared with wild type or cells expressing the 
rescue construct. 
MDCK cell culture and transfection 
MDCK canine kidney cells were cultured in 1X MEM (Gibco) containing 10% FBS 
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(Invitrogen) and 50 µg/mL penicillin/streptomycin. If the cells were grown on filters 
media was applied above the cells on the filter as well below the cells in the well in 
which the filter was placed. Nucleofections (Amaxa cell line Nucleofection Kit L) was 
used to transfect MDCK cells with siRNAi directed against Ajuba and LIMD1, according 
to the manufacturer’s instructions. Equal numbers of cells were immediately plated on 
three different sized dishes so as to have cells plated at low, medium and high densities. 
Forty-eight hours after nucleofection the cells were harvested for immunoblot analysis.   
 
MDCK and PDV Immunofluorescence on Cover slips and filters: 
 
MDCK cells as well as PDV cells were plated at desired confluency on cover slips. If 
using filters for MDCK cells (Transwell, 6.5 mm diameter [3495 Cat #] or 12 mm 
diameter, 0.4micron pore ize by corning) cells must be a monolayer. When ready, the 
cover slips (or filters) were rinsed once with PBS (1X) and then fixed in 4% 
Paraformaldehyde. If using filters, cells were fixed in Borisy Stabilization Buffer- 10mM 
Pipes, pH6.5; 127mM NaCl; 5mM KCl; 1.1mM NaH2PO4; 0.4mM KH2PO4; 2mM 
MgCl2; 5.5mM glucose; 1mM EGTA; 4% Paraformaldhyde). The Borisy Stabilization 
Buffer was made as a 2X stock and stored at 4C. After fixation, the process can be 
stopped by washing the cover slips/filters 3X times in PBS (5min each) and storing the 
cells in the last PBS wash at 4C. Next the cells were permeabilized by washing them 3X 
times, 5min each wash, in PBST (PBS + 0.2% Triton X-100).  If the LIMD1 or WTIP 
antibody was used the cells were further subjected to Guanadine Hydrochloride treatment 
(GHCl). Cells were treated with 6N GHCl for 10min at Room Temp. Following this, the 
cells (cover slips and fliters) were washed thoroughly with PBS. For these washes 3 
beakers with PBS were set up and each cover slip or filter was dipped10-15 times in each 
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beaker to make sure all the GHCl has come off). After the GHCl step, the cells were 
blocked for 1hr in PBST + 3% BSA (IgG free). After blocking, the cells were incubated 
in primary antibody for 1hr at 37C (Antibodies were diluted in PBST +3% BSA and then 
spun down 20min at 4C before using). After the primary antibody incubation, the cells 
were wash 3X times for 5min each in PBST. Next, the cells were incubated with 
secondary antibody. Once again, the antibody was diluted in PBST +3% BSA and spun 
down for 20min at 4C before using. The cells were incubated in secondary antibody for 
30min at 37C or Room Temp. The cells were then washed 3Xtimes in PBS. If using 
DAPI to stain nuclei, incubate cells for 5 min in DAPI (1:1000 in PBS) at Room temp 
and wash 3X for 5 min each with PBS. If using cover slips, mount cover slips on glass 
slides and seal with nail polish. Vectasheild mounting media was used (with or without 
DAPI). If using filters, at this point, filters were cut out using sharp scalpels and placed 
facing up (cells on top and filter towards the glass slide) on the slides. Mounting media 
was applied and a cover slip was placed on top before sealing with nail polish.  
Antibodies for immunofluorescence were used at: Rab anti-Ajuba: 1:250, Rab 
anti-LIMD1 (Affinity purified from Wistar): 1:250, WTIP: 1:250 and Mouse anti-E-
cadherin: 1:500. Secondary antibodies were used at 1:250. In case of cover slips, the top 
of a 12 well dish was covered in parafilm and then 30 microliters of the antibody 
(primary or secondary) was applied. The cover slip was then placed (cells down toward 
the antibody drop) to incubate. If using filters between 100-300 microliters of antibody 
was applied to the filters. In both cases, the 12 well dishes were placed in a tupper ware 
(either with a lid or with paraflim) box lined with water-soaked tissue to prevent the 




Immunoblotting and Antisera used 
 
Cells were lysed in RIPA buffer [150 mM NaCl, 10 mM Tris-HCl (pH 7.5), 1mM EDTA, 
1% Triton-X100, 0.35% DOC, 0.25% NP-40, 0.1%SDS], PMSF and protease inhibitor 
cocktail (Sigma). Lysates were then cleared by centrifugation and boiled for 5 minutes in 
SDS sample buffer and resolved by 10% SDSPAGE, under reducing conditions. Proteins 
were transferred to nitrocellulose in transfer buffer (48mM Tris, 390mM, glycine, 0.1% 
SDS, 5% methanol) and immunoblots were probed with primary antibodies: rabbit α-
Ajuba (1:1000), mouse α –Ecadherin (1:1000), rabbit α- LIMD1 (1:1000) and Wtip: 
1:1000.  For quantification, blots were minimally exposed and then scanned for 
















Figure 1: Schematic representation of a polarized epithelial cell. Adapted from 
Miyoshi J and Takai Y Jan 5; (57):815-55. Tight junction- TJ, Adherens junction- AJ. TJ 
proteins Occludin, Claudin and JAM are connected to the actin cytoskeleton via the ZO 











































Figure 2: Ajuba is rapidly recruited to newly formed cell-cell contacts in 
keratinocytes. (A) Western blot analyses of Ajuba subfamily members (Ajuba and 
LIMD1) and Zyxin family members (LPP, TRIP6 and Zyxin) in primary mouse 
embryonic fibroblasts (MEF) (left column) and primary mouse keratinocytes (right 
column) with equal amounts of protein loaded in each lane. (B) Cells grown in low 
calcium medium loose cell-cell adhesion and E-cadherin (red) and Ajuba (green) proteins 
are internalized into the cell. Cells from Low calcium media (Column 1) were then 
transferred to standard medium for 5min (Column 2), 15min (Column 3) or 60 min 
(Column 4) to induce the formation of cell-cell contacts. Cells were stained for E-
cadherin (a, d, and g) and Ajuba (b, e, and h). Merged images are shown in the bottom 
row. The four columns in the merge images show the distinct staining pattern of Ajuba 
(green) and E-cadherin (red) in the absence of junction formation. However with the 
addition of calcium and Ajuba and E-cadherin get recruited to the same compartments at 
the newly formed junctions.  
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Adapted from Marie et al. 2002 
Figure 2 
 61 
Figure 3: Primary keratinocytes from Ajuba knock out mice display defects in 
junctional stability. Adapted from Marie H et al. J. Biol. Chem. January 10, 2003; 
278(2): 1220-1228. Primary keratinocytes isolated from Ajuba null and wild type 
newborn littermates. A, once confluent, cells were switched to low calcium medium, to 
initiate cell-cell junction formation, calcium was added back into the media. Cells were 
fixed and stained for E-cadherin. Significant gaps remain between cells even though E-















Figure 4: Ajuba localizes to the Adherens junctions. (A-A’’) MDCK cells plated on 
collagen filters and allowed to polarize and then fixed and stained with E-cadherin (A), 
Ajuba (A’) and merged (A’’). (B) Z- stack view of the merged images from A’’ showing 





Figure 5: (A) Map of the lentivrial vector pFLRu containing 2 multiple cloning sites 
(MCS); MCS at 5’ of Ubic for the shRNA expression cassette, and 3’ of Ubic for the 
RNAi-resistant isoform of shRNA targeted gene containing an in-frame C-terminal GFP 


























Figure 6. Ajuba knockdown in MDCK cells. Ajuba shRNAs were generated against 
canine Ajuba sequence and expressed in MDCK cells. Control samples expressed 
shRNAs against luciferase. (A) Immunofluorescence staining of cells expressing 
luciferase shRNA or Ajuba shRNA with GFP tags. (B) Western blot analysis of cell 
lysates from control, Ajuba kd and rescue cells, actin was used as the loading control. (C) 
MDCK cells knocked down for Ajuba and LIMD1 using tranisent Ambion dsRNA oligos 
using nucleofections and blotted for various junctional proteins as labeled.  





















Figure 7: Calcium Switch in MDCK cells. (A) Cells are originally plated on collagen 
transwell filters so as to form a polarized monolayer of cells in normal calcium media. 
(B) When Calcium is withdrawn from the cell media the cells loose calcium dependant 
junctions and all junctional proteins become cellularized. (C) Finally the process can be 
reversed by the re-addition of calcium (a calcium switch), which allows for the rapid 






















Figure 8.  Knockdown of the LIM proteins results in aberrant cell morphology.    (A-
B)  Phase contrast images of PDV control (A) and Ajuba knockdown lines showing 
altered cell morphology (B). (C-D) Confocal images of MDCK cells stained with E-
cadherin in red and subject to control RNAI using Luc siRNA (C) and Ajuba and LIMD1 
siRNA (D). (E-G) Z-stack analysis of confocal images of MDCK control (E), Ajuba 
knockdown (F), and rescue cell lines (G).  YFP (green) shows infected cells, E-cadherin 





















Figure 9: Ajuba deficiency delays recruitment of cadherin TJ protein Occludin and 
AJ protein E- to nascent junctions. (A-H) MDCK cells plated on collagen filters and 
grown in standard media until a confluent layer of cells was formed and then switched to 
LCM for 10-12 hrs, after which the media was switched back to HCM to induce a 
calcium switch. (A-D) Wild type cells (A-A’’), Ajuba knock down cells (B-B’’), LIMD1 
knock down cells (C-C’’) and Ajuba and LIMD1 double knock down cells (D-D’’) 
stained for AJ protein E-cadherin, fixed before reintroducing calcium (0 min), 2 hours or 
6 hours after addition of calcium. (E-H) Wild type cells (E-E’’), Ajuba knock down cells 
(F-F’’), LIMD1 knock down cells (G-G’’) and Ajuba and LIMD1 double knock down 
cells (H-H’’) stained for AJ protein E-cadherin, fixed before reintroducing calcium (0 












Figure 10: Ajuba knock down cells have weakened cell-cell adhesion: (A) Stable lines 
of MDCK epithelial cells, expressing either Luc shRNA or Aj shRNA were aliquoted 
into 50 ul drops and placed on the underside of the lid of a dish. The drops were allowed 
hang down for 4 hours. At every hour the number of aggregates (3-5 cell, 5-10 cells, 11-
50 cells and >50 cells) formed were counted by phase microscopy before and after 
trituration (carried out by a 20ul pipette tip) for each cell line.  (B-E) Control MDCK 
cells (B, C) and Aj RNAi cell (D, E) aggragates were counted for thei size and number of 
cells within the aggregate before trituration (B and D respectively) and after trituration (C 
and E respectively). (F-I) The aggragate size and number were then graphically 










Figure 11:  Cells lacking Ajuba show delayed tight junctions formation. (A) Stable 
lines of MDCK expressing either Luc shRNA, Aj shRNA or AjshRNA-mAj-YFP were 
plated on collagen filters. Once the cells formed a confluent layer, normal media was 
switched to low calcium media for 10-12 hrs, after which the media was switched back to 
high calcium media. The TER was then measured at every hour for 10 hours following 
the addition of calcium in the media. (B) A graphical representation of the TER 
measurements taken from control cells, Ajuba knock down cells and Ajuba knock down 












Figure 12: WTIP knock down in MDCK cells via nucleofection. (A-A’’)  MDCK cells 
stained for WTIP in green and E-cadherin in red in control Luc siRNA cells (A-A’’) and 
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 The mammalian Ajuba LIM proteins (Ajuba, LIMD1, WTIP) are cytosolic 
adapter proteins recruited to nascent epithelial adherens junctions, where they are thought 
to contribute to junctional assembly and/or stability (Marie, Pratt et al. 2003).  They also 
shuttle into the nucleus acting as corepressors of the Snail family of transcriptional 
repressors, thereby contributing to epithelial mesenchymal transition (Langer, Feng et al. 
2008). As such they have the potential to communicate cell adhesive events with nuclear 
responses to remodel epithelia.  Determining their role(s) in vivo, however, has been 
challenging due to shared interacting proteins, overlapping tissue expression and 
functional redundancy in cells. Thus, we turned to the Drosophila model system where a 
single gene, CG11063 or djub, exists. The generation and analysis of Drosophila 
containing djub mutant loss-of-function alleles or depleted of dJub by RNAi identify djub 
as an essential gene required for normal development and a novel regulator of epithelial 
organ growth as a component of the conserved Hippo pathway, which has been 
implicated in both tissue size control and cancer development (Tapon, Harvey et al. 2002; 
Iida, Hirota et al. 2004; Lai, Wei et al. 2005). djub-deficient epithelial tissues were small 
due to decreased cell numbers resulting from increased apoptosis and decreased 
proliferation due to the downregulation of DIAP1 and cyclin E, phenocopying tissues 
deficient for Yorkie (Yki), the downstream target of the Hippo pathway. djub genetically 
interacts with the Hippo pathway, and genetic epistasis suggests that djub influences wts 
activity. In mammalian and Drosophila cells, Ajuba LIM proteins/dJub specifically 
interact with LATS/Wts and WW45/Sav to inhibit phosphorylation of YAP/Yki. This 
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During development cell intrinsic as well as extrinsic factors coordinate to specify 
organ or tissue specific cell size and number. For all the diverse cell types, the final 
number of cells is determined by a balance of cell proliferation and cell death. Normal 
healthy tissue and the cells within cease to proliferate and grow once they have reached 
their final size. The question still remains of how these processes are regulated in normal 
healthy tissue and how cancer genes first initiate proliferation, which can then disrupt the 
intricate epithelial architecture.  
Recent studies have established the role of the Hippo pathway in regulating size 
in Drosophila (Tapon, Harvey et al. 2002; Iida, Hirota et al. 2004; Lai, Wei et al. 2005) 
and has been implicated in cancer development in humans (Overholtzer, Zhang et al. 
2006; Dong, Feldmann et al. 2007; Zhao, Wei et al. 2007; Steinhardt, Gayyed et al. 
2008). The activation of the pathway enfolds a kinase cascade where Hpo, a Ste-20-type 
kinase, forms a complex with Salvador (Sav), a WW-repeat adapter protein, and then 
activates Warts (Wts), a nuclear Dbf-2-related type kinase, by phosphorylation. Wts in 
turn binds to the Mats, Mob-as-tumor-suppressor protein, and phosphorylates the 
transcriptional coactivator Yorkie (Yki) at the Serine 168 site (Harvey, Pfleger et al. 
2003; Pantalacci, Tapon et al. 2003; Udan, Kango-Singh et al. 2003). Phosphorylated Yki 
binds 14-3-3 proteins, which inhibit Yki from shuttling into the nucleus and induce the 
transcription of the Hpo pathway target genes. Yki has been ascertained to be an activator 
of proliferation and anti-apoptotic genes (Dong, Feldmann et al. 2007; Zhao, Wei et al. 
2007). Also integral to the pathway is the ERM (ezrin/radixin/moesin) domain containing 
cytoskeleton proteins, Merlin (Mer) and Expanded (Ex) and the protocadherin Fat (Ft) 
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that are upstream of the pathway and function in the activation of the signaling cascade 
(Bennett and Harvey 2006; Badouel, Gardano et al. 2009).  
Loss of function mutants of hpo, sav, wts and overexpression of yki all result in 
overgrowth of Drosophila epithelial tissue. The increase in proliferation and decrease in 
apoptosis is brought about by the misregulation of yki transcriptional targets such as 
cyclinE , Drosophila inhibitor of apoptosis protein DIAP1 and the microRNA bantam 
(Nolo, Morrison et al. 2006; Willecke, Hamaratoglu et al. 2006). Studies have also shown 
that the mammalian components of the Hpo/Sav/Wts/Yki pathway, namely Mst1/2, 
WW45, Lats1/2 and YAP and their size regulatory function are conserved in mammals. 
Furthermore, the Drosophila loss of function mutants for yki, wts and hpo can all be 
functionally rescued by their mammalian orthologs, YAP, Lats1 and Mst2 respectively 
(Tao, Zhang et al. 1999; Harvey, Pfleger et al. 2003; Dong, Feldmann et al. 2007). 
Our studies have identified a novel negative regulator of the Hpo growth 
regulatory pathway, namely, the Ajuba LIM proteins. The family of Ajuba LIM proteins, 
namely Ajuba, LIMD1 and WTIP are closely related to the Zyxin (Zyxin, LPP, Trip6) 
family of LIM proteins. These proteins contain 3 homologous C-terminal protein 
interacting LIM domains and unique prelim region on their N-terminal region.  Ajuba 
LIM proteins can be found in the cytosol, plasma membrane associated, or nuclear.  In 
each subcellular compartment they appear to have distinct functions.  They are present in 
most epithelia, in varying relative amounts.  In epithelial cells Ajuba is actively recruited 
to newly forming cell-cell adhesions through an association with a-catenin bound to 
surface E-cadherin, where it can influence cell-cell adhesion formation or stabilization 
(Marie, Pratt et al. 2003).  Ajuba LIM proteins also shuttle into the nucleus where they 
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have been shown to function as transcriptional co-repressors for Retinoblastoma protein 
(LIMD1) and Snail family proteins, where they can influence developmental epithelial 
mesenchymal transitions (EMT) (Goyal, Lin et al. 1999; Marie, Pratt et al. 2003).  These 
results suggest that the Ajuba LIM proteins have the capacity to communicate cell 
surface events (adhesion) with nuclear responses (EMT, tumor transformation). These 
roles of the Ajuba family of LIM proteins make them excellent candidates for the 
coordination of cell surface roles resulting in a nuclear response. Since all three family 
members have largely overlapping expression in epithelia, albeit at different relative 
levels, a determination of their role in development, in vivo, has proven challenging.  
Both Ajuba-/- and LIMD1-/- mice are viable, and although LIMD1 mice are somewhat 
smaller, both develop normally.  Likewise Ajuba/LIMD1 double null mice are also viable 
and develop normally.    
 To determine what role, if any, the Ajuba LIM proteins have in development, 
specifically in epithelial development, we decided to approach this problem in 
Drosophila. The main advantages of using the Drosophila as a model to ask our question 
was that flies have only a single Ajuba LIM protein family gene, CG11063 on the X 
chromosome, thereby significantly reducing potential functional redundancy issues 
apparent in prior mouse experiments.  Secondly, the fly system is well established as a 
model to study epithelium and the genetic tools available allow studying the effects of 
manipulating a gene in an in vivo system. To determine the role of Ajuba LIM proteins in 
epithelial development we generated drosophila lines expressing two different RNAis 
directed against CG11063 and also a genetic null allele of CG11063, namely djub.  
 In the studies presented here we show that djub is an essential gene necessary for 
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normal Drosophila development. Moreover, our data suggest that djub regulates 
expression of CycE and DIAP1, key regulators of cell cycle progression and apoptosis. 
We provide evidence that djub acts through the Hippo pathway to regulate tissue size. 
Also djub acts genetically and biochemically upstream of Wts/LATS.   Taken together 





















The Drosophila orthologue of mammalian Ajuba LIM proteins, dJub, regulates 
organ size 
 In Drosophila there is a single orthologue of the mammalian Ajuba subfamily of 
LIM proteins encoded by the CG11063 locus in the X chromosome (Renfranz, Siegrist et 
al. 2003). CG11063 exhibits greater sequence similarity to the three mammalian Ajuba 
subfamily proteins, than to dZyx, the Drosophila orthologue of the Ajuba-related Zyxin 
subfamily of LIM proteins (Zyxin, LPP, and Trip6) (Fig. S1A). We designate CG11063 
as djub (Drosophila Ajuba LIM proteins).    
 To determine the in vivo function(s) of djub in Drosophila we generated two 
different dJub RNAi lines: djub-RNAi 22.5 and djub-RNAi 18.1 (Fig. S1A). Ubiquitous 
expression of either, using GAL4/UAS and actin-GAL4, resulted in pharate lethality, 
suggesting that djub is an essential gene. Both RNAi constructs yielded similar 
phenotypes in all subsequent assays. Since djub-RNAi 22.5 consistently induced stronger 
phenotypes we use RNAi 22.5 when referring to dJub RNAi.  
 Since Ajuba LIM proteins are abundant in mammalian epithelia (Goyal, Lin et al. 
1999) and have been implicated in epithelia functions (Marie, Pratt et al. 2003), we 
selectively depleted djub function in larval wing and eye imaginal disc epithelium. djub 
RNAi expression in the wing, using 1096-gal4, decreased wing size to 65% of wild type 
(Fig. 1B and E). Western blot analysis of tissues expressing dJub RNAi revealed an 
approximate 60% reduction of dJub protein level (Fig. 1H). The small wing phenotype 
was due to decreased cell number, not cell size, and wing patterning appeared unaffected 
(Fig. 1F).  Similarly, GMR-GAL4-mediated expression of dJub RNAi in the pupal eye 
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epithelium resulted in a 25% reduction in interommatidial cells, without significant 
disruption to ommatidial patterning (Fig. 1J, K).  These RNAi phenotypes were specific 
for dJub depletion, as overexpression of a wt djub transgene in dJub RNAi-expressing 
cells partially rescued both wing and eye phenotypes (Fig. S1D, H). Furthermore, 
overexpression of human LIMD1 (most closely related to dJub) also rescued the dJub 
RNAi wing phenotype (Fig. S1G, H), suggesting that this function of Ajuba LIM proteins 
is conserved between Drosophila and mammals. dJub and hLIMD1 overexpression in wt 
wings and eyes also resulted in a modest increase in size, due to increased cell number 
(Fig. 1C, E, F, R and data not shown). In pupal eye epithelium dJub localized to adherens 
junctions (AJs), predominantly in interommatidial cells, co-localizing with DE-cadherin 
in a punctate pattern (Fig. 1L-O). The HA-LIMD1 transgene also localized to AJs in 
wing larval disc epithelia (Fig. S1I). This cellular localization of dJub is similar to that 
for mammalian Ajuba LIM proteins in mammalian epithelia (Marie, Pratt et al. 2003). 
 We next generated djub mutant alleles using FLP-FRT based methods (Parks, Cook 
et al. 2004). Two distinct, yet overlapping, deficiencies of the djub locus were made (Fig. 
S2). The first alelle, djub I deletes djub, CG11092 and the 5’ region of CG10997 (Fig. 
S2A). The second allele, djub II removes djub and CG32626 and the 3’most region of 
CG11092 (Fig. S2A).   In addition, both deficiencies yielded identical results for all 
phenotypic studies detailed below.  Flies hemizygous for each deficiency died at late 
embryonic to first instar larval stage. Female flies (heterozygous for djub I or djub II) 
expressed 50% level of WAL-d protein, as determined by Western blot (Fig. S2C). 
Importantly, ubiquitous expression of wt djub transgene rescued lethality of both alleles, 
confirming that the loss of djub, and not the flanking genetic material, was responsible 
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for this phenotype and that djub as an essential gene.   
 When dJub was selectively deleted in the eye, using eyeless-FLP (EGUF/hid) to 
produce eyes composed of over 90% djubI mutant cells (Stowers and Schwarz 1999), 
adult eyes were severely reduced in size (Fig. 1Q). Genetic mosaic analysis of djubI 
mutant and wt twin-spot clones in eye and wing imaginal discs resulted in djubI mutant 
clones (Fig 1T, U yellow arrows) that were significantly smaller than wt twin-spot clones 
(Fig 1S, U red arrow).  To verify that these growth defects were specific to loss of djub 
function, we induced djubI mutant clones throughout the wing imaginal disc while 
simultaneously expressing a wt mCherry-tagged djub transgene only in the posterior half 
of the wing disc using engrailed-gal4. In the anterior compartment djubI mutant clones 
were small and few in number (Fig. S2E). In contrast, the posterior compartment 
contained more and larger clones, similar to wt clones induced in a wt background (Fig. 
S2D-F).  
 
djub mutant clones exhibit reduced proliferation and increased apoptosis  
 The growth phenotype of djubI mutant clones could result from decreased cell 
proliferation and/or increased apoptosis. In wt larval eye imaginal discs undifferentiated 
cells lie anterior to the morphogenetic furrow and undergo asynchronous cell divisions 
(Fig. 2A, white arrow).  Posterior to the furrow cells either differentiate or undergo one 
more cell division – the second mitotic wave (Fig. 2A, yellow arrow) – after which they 
differentiate or die (Ready, Hanson et al. 1976; Tomlinson and Ready 1987). 
Bromodeoxyuridine (BrdU) labeling of wt and djubI mutant eye discs, generated via the 
EGUF-Hid method, revealed that djubI eye discs displayed a strong reduction in the 
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number of cells undergoing asynchronous cell division anterior to the furrow (Fig. 2A’, 
white arrow) and a near complete loss of the second mitotic wave (Fig. 2A’, yellow 
arrow).  During eye development apoptosis determines the final number of cells in the 
eye (Baker 2001). Staining eye discs for activated caspase-3 revealed that djubI mutant 
eye discs contained increased number of caspase-3-positive cells (Fig. 2B, B’), and when 
the caspase inhibitor P35 was coexpressed throughout a djubI mutant adult eye the small 
eye phenotype was partially rescued (Fig. S3B, C). Relative to wt, djubI mutant clones 
exhibited decreased levels of Drosophila inhibitor of apoptosis-1 (DIAP1) (Fig. 2C) and 
Cyclin E (Fig. 2E). dJub appeared to control transcription of DIAP1 as djubI mutant 
clones expressed less lacZ, under control of the diap1 gene promoter (Fig. 2D). These 
data indicate that dJub regulates organ size by inhibiting apoptosis and promoting cell 
proliferation through influencing DIAP1 and Cyclin E expression, respectively. Although 
loss of dJub reduced eye size, photoreceptors cells (ELAV-positive cells) still developed 
(Fig. S3A), suggesting that dJub did not influence cell specification steps and that the 
differentiated cells did not require dJub for their survival. Furthermore, dJub deletion did 
not affect adherens junction organization, as determined by DE-cadherin staining of djubI 
mutant clones (Fig. S3D). 
 
DJub genetically interacts with the Hippo pathway    
 The djub loss of function phenotype resembles that of yorkie (yki), which encodes 
a transcriptional coactivator, the activity of which is antagonized by the Hippo signaling 
pathway. Active Yki promotes proliferation and inhibits apoptosis by facilitating 
transcription of Cyclin E and DIAP1 (Huang, Wu et al. 2005; Oh and Irvine 2008). Given 
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the similarity between the djub and yki loss of function phenotypes we hypothesized that 
dJub governs organ size by affecting Yki activity either directly, or indirectly by 
inhibiting Hippo pathway function.   Hippo pathway mutants (hpo, sav, wts) produce 
overgrown adult eyes and pupal eyes with increased interommatidial cells (Fig. 3C, E, G, 
and J, J’, L, L’, N, N’, P respectively) (Harvey, Pfleger et al. 2003; Udan, Kango-Singh et 
al. 2003). Removing a copy of djub reduced the magnitude of hpo and sav mutant 
phenotype (Fig. 3D, K, K’, P and F, M, M’, P), and modestly affected the wts phenotype 
(Fig. 3H, O, O’, P). In a reciprocal manner, a 50% reduction in Wts suppressed the dJub 
RNAi small wing phenotype (Fig. S4A-E), while a 50% reduction of Yki enhanced this 
phenotype (Fig. S4F-J). Taken together these two analyses suggest the possibility that 
djub and the Hippo pathway genetically interact. If so, then djub specifically interacted 
with the Hippo pathway of organ growth control as no genetic interactions were observed 
between dJub and Myc or components of the Insulin receptor signaling pathway, known 
to regulate organ size by affecting cell size (Fig. S4K). DJub localization to AJ was 
unaltered in wts, hpo, and sav mutant pupal eyes (Fig. S3E-G). 
  
Epistatic analysis suggests that djub acts upstream of wts and yki but downstream of 
hpo                                                                                                                                  
 If djub genetically interacts with the Hippo pathway then there should be an 
epistatic relationship to components of the Hippo pathway. To determine where in the 
Hippo pathway dJub acts we performed genetic epistasis experiments between djub and 
yki, wts and hpo. MARCM pupal eye clones of djubI alone result in small clones (Fig. 4B, 
I), whereas MARCM clones overexpressing Yki or depleted of Wts or Hpo result in 
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increased clonal area as well as overproliferation of interommatidial cells (Pantalacci, 
Tapon et al. 2003; Wu, Huang et al. 2003; Huang, Wu et al. 2005; Edgar 2006) (Fig. 4C, 
E, G, I and Fig. 5C, E, G and I, respectively). djubI mutant MARCM clones 
overexpressing Yki displayed a phenotype identical to overexpression of Yki alone (Fig. 
4D, I and Fig. 5D, I). djubI mutant MARCM clones depleted of Wts, resembled wts 
RNAi clones (Fig. 4F, I and Fig. 5F, I), however, removing djub in hpo RNAi MARCM 
clones resulted in a djubI-like phenotype (Fig. 4H, I and Fig. 5H and I). This epistatic 
analysis suggested that djub acts downstream to hpo but upstream of wts and yki, but 
since the core Hippo pathway proteins (Hpo, Sav, Wts, and Mats) are thought to function 
as a complex, a precise epistatic relationship is difficult to conclude.  
 
Ajuba LIM proteins/dJub  associate with LATS/Wts and WW45/Sav in mammalian 
and Drosophila cells, respectively,  and influence YAP activity in mammalian cells 
The Hippo pathway is highly conserved between Drosophila and vertebrates 
(Tao, Zhang et al. 1999; Wu, Huang et al. 2003; Lai, Wei et al. 2005; Dong, Feldmann et 
al. 2007), and human LIMD1 rescues the cell growth defects of dJub depleted Drosophila 
wings (Fig. S1G, H). To determine whether Ajuba LIM proteins interact with Hippo 
pathway components in cells, and if so whether these interactions are functionally 
relevant, we tested whether the mammalian homologs of dJub (Ajuba, LIMD1 and 
WTIP) associated with mammalian orthologues of Hippo pathway members in human 
HEK293 epithelial cells, through co-immunoprecipitation experiments. All three Ajuba 
subfamily members associated strongly with LATS1/2, and Ajuba and WTIP associated 
 99 
with WW45, but none associated with MST1/2 or YAP (Fig. 6A-C). The interaction 
between LATS and WW45 and Ajuba family proteins was specific as Zyxin, the most 
closely related LIM protein to Ajuba family members, failed to associate with either 
LATS or WW45 (Fig. 6D). In transfected Drosophila S2 cells dJub associated with Wts 
and Sav but not Hpo (Fig. S4L left panel). A weak association between dJub and Yki was 
noted but this was >10 fold less than that observed for Wts and Sav, and may well be 
nonspecific as transfected Yki was massively overexpressed in S2 cells (Fig. S4L, right 
panel). 
 To determine if these protein-protein interactions were functionally relevant we 
asked whether Ajuba LIM proteins affected YAP activity (i.e., YAP phosphorylation) 
(Dong, Feldmann et al. 2007; Oh and Irvine 2008; Reddy and Irvine 2008). Transfection 
of MST1, WW45, LATS1/2 alone into HEK293 cells resulted in variable increase in 
phospho-S127-YAP levels, however, when co-transfected with LIMD1 phospho-YAP 
levels were decreased in all instances (Fig. 6E). Overexpression of dJub in drosophila 
imaginal discs did not appreciable change the level or subcellular localization pattern of 
Yki or other Hippo pathway targets namely, Ex and Diap1. This may be due to the fact 
that only a small 10% increase in wing size occurs in wings overexpressing dJub (Fig. 
1C, E, F). In another approach, Ajuba and LIMD1 were RNAi-depleted in MDCK cells, 
and phospho-YAP levels determined in cultures of cells at differing density. Analysis of 
MDCK cells depleted of all three Ajuba LIM proteins was not possible as cells died, like 
drosophila cells lacking dJub. Compared to control MDCK cells, in cells depleted of 
Ajuba and LIMD1 basal phospho-YAP levels were increased 2.5 fold in all three 
densities (Fig. 6F). Taken together, these results demonstrated that mammalian Ajuba 
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LIM proteins and dJub specifically associate with LATS/Wts and WW45/Sav in cells, 
























The recently described Hippo pathway has been established as one of the vital 
mechanisms that restrict organ size in Drosophila, and is well conserved in mammals as 
well (Tapon, Harvey et al. 2002; Iida, Hirota et al. 2004; Lai, Wei et al. 2005). Moreover 
mutations in components of the Hippo pathway have been implicated in the development 
of human cancers (Tapon, Harvey et al. 2002). The pathway accomplishes this by 
controlling the function/subcellular localization of the transcriptional coactivator Yki 
through a core protein kinase cascade (Hpo and Wts) that leads to selective 
phosphorylation of Yki, by Wts, resulting in the cytoplasmic accumulation of Yki, and 
thus, transcriptional inactivity (Huang, Wu et al. 2005; Oh and Irvine 2008). We now 
report that the single Drosophila ortholgue of the Ajuba LIM protein family, djub, 
impinges on the function of Yki by inhibiting the Hpo pathway.   Both biochemical and 
genetic evidence implicates dJub as a negative regulator of the Hpo/Wts pathway.   In the 
first instance, mammalian Ajuba, LIMD1 and WTIP as well as Drosophila dJub LIM 
proteins specifically associate with Lats (Wts) and WW45 (Sav) in cells and their 
overexpression limits the phosphorylation of YAP (Yki) (Fig. 6 and Fig. S4).  In 
Drosophila djub genetically interacts with Hpo pathway mutants, and based on epistasis 
analysis djub appears to act upstream of yki and warts yet downstream of hpo.   
We provide several lines of genetic evidence that places the activity of djub 
downstream of Hpo and upstream of Wts.  First, the growth defect of djub null mutants is 
phenotypically similar to yki loss of function and hpo and wts gain of function 
(Hamaratoglu, Willecke et al. 2006), where tissue size is severely reduced due to an 
increase in apoptosis and a decrease in cell proliferation with a corresponding 
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downregulation of the target genes DIAP1 and Cyclin E. (Fig. 1P, Q and Fig.2 C-E).  
Second, the phenotypes induced by removing hpo, wts or sav in the eye are reversed by 
removing one copy of djub (Fig. 3). Similarly, removing one genomic copy of wts 
suppresses the dJub RNAi phenotype while removing one genomic copy of yki enhances 
the dJub phenotype (Fig. S4). Third, the epistasis experiments show that overexpressing 
Yki and Wts RNAi in the absence of djub manifests as a Yki overexpression and a Wts 
RNAi phenotype respectively, and the Hpo RNAi phenotype persists in the absence of 
djub, indicating that the Wts RNAi and Yki overexpression phenotypes do not require the 
activity of djub, suggesting that djub functions upstream of wts and yki. The fact that the 
Hpo RNAi phenotype is masked in the absence of djub suggests that hpo functions 
upstream of djub (Fig. 4, 5, and 6).  These genetic and biochemical data (Fig. 6) suggest 
the possibility that dJub may influence the Hpo pathway by affecting Wts activity. 
Precisely how Ajuba LIM proteins (dJub) influence LATS/Wts mediated inactivation of 
YAP/Yki remains to be determined, but possibilities include: inhibition of activation of 
LATS/Wts by upstream kinases (MST/Hpo), inhibition of the ability of LATS/Wts to 
phosphorylate YAP/Yki, or affecting the subcellular localization of LATS/Wts or 
WW45/Sav and thus their access to the Hippo pathway. Moreover, the regulatory 
relationship between Ajuba LIM proteins (dJub) and LATS/Wts may not be simply 
unidirectional as LATS has been shown to phosphorylate Ajuba (Abe, Ohsugi et al. 
2006).  
Although this is the first time the Ajuba family of LIM proteins have been 
implicated in the Hpo pathway, prior work has described an interaction between Ajuba 
and LATS at centrosomes that influences mitotic centrosome/spindle organization. That 
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study showed that Ajuba and Lats2 co-localize to centromeres and further, associate with 
each other during mitosis. This interaction requires the kinase activity of Lats2 and 
results in the phosphorylation of the LIM protein Ajuba (Abe, Ohsugi et al. 2006).  With 
respect to the Hippo pathway there is some data that shows Mats and Wts colocalize at 
the centrosome (Shimizu, Ho et al. 2008). Therefore we cannot exclude the possibility of 
the cenrtrosome being a functional site for the interactions, as mitotic damage can lead to 
apoptotic cell death, nor that dJub’s effects upon the Hpo pathway are cell cycle 
dependent.  
Ajuba LIM proteins are components of AJs in mammalian and Drosophila 
epithelia. Upstream members of the Hippo pathway include atypical cadherins (Fat, 
dachsous), and Expanded and Merlin – also localize to adherens junctions, leading to the 
hypothesis that AJs could be nodal points for initiation/regulation of Hippo signaling 
(Bennett and Harvey 2006; Cho, Feng et al. 2006; Silva, Tsatskis et al. 2006; Willecke, 
Hamaratoglu et al. 2006; Feng and Irvine 2007; Tyler and Baker 2007; Reddy and Irvine 
2008), however how these upstream components actually activate MST/Hpo kinase is 
unknown.  The Hippo pathway is thought to regulate cell contact growth inhibition 
(Zhao, Wei et al. 2007). Interestingly, in sub-confluent non-contacted cells, Ajuba LIM 
proteins are cytosolic while YAP is nuclear and cells proliferate (Zhao, Wei et al. 2007). 
When cells achieve confluence Ajuba proteins are recruited to AJs while YAP is 
phosphorylated and re-localized to the cytosol and cell proliferation ceases. Whether 
these events are related is not known, but given that Ajuba proteins associate with and 
inhibit LATS/Wts-mediated phosphorylation of YAP raises the possibility that the 
recruitment of Ajuba proteins/dJub to AJ in confluent cell cultures may “release” 
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LATS/Wts allowing for Hippo pathway mediated YAP/Yki phosphorylation, 




















Experimental Procedures and Materials 
 
Drosophila genetics and strains 
djub RNAi lines 
djub RNAi constructs were cloned as inverted repeats (Bao and Cagan 2006). Briefly, an 
approximately 500bp fragment of the coding region was amplified from a Canton S 
cDNA library and subcloned into pGem-WIZ (Bao and Cagan 2006). Subsequently a 
copy of the fragment was inserted in the opposite direction. The mini-white gene 
separated the inverted fragments. The entire piece “fragment – mini-white – inverted 
fragment” was then sub-cloned into pUAST, and this vector was used to generate 
transgenes via standard P element-mediated transformation (Rainbow Transgenics, Inc). 
UAS-djub-RNAi 22.5 targets a 445bp fragment starting at 226bp before the start codon 
and UAS-djub-RNAi 18.1 targets the 593bp fragment starting 500bp after the start codon 
(Fig. S1A). 
 
Generation of djub deficiency lines 
Djub deficiencies were generated as described in Parks, A.L et al (Parks, Cook et al. 
2004). djub I was generated by FRT-mediated recombination between PA (P[XP]d05713) 
and PB (PBac[RB]CG11063e03614 ) in flies heterozygous for chromosomes bearing each 
P element (Fig. S1A). djub II was generated by FRT-mediated recombination between PX 
(PBac[RB]CG11092e03640 ) and PY (P[XP]d02874) (Fig. S1A). Genomic deletion was 
confirmed by PCR, and immunoblotting for djub gene product (Fig. S1B).  
 
Construction of djub-mCherry and HA-LIMD1 transgenes 
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cDNA was prepared from tissue obtained from 3rd instar larvae. The tissue was 
homogenized in Trizol and chloroform (1:5) and then subjected to centrifugation. The 
mRNA was precipitated with 100% isopropanol and the pellet was washed in RNAse free 
75% ethanol. The pellet was dissolved in DEPC-dH2O and the DNA digested by DNAse 
treatment. The mRNA was extracted with a pheno-chroloform isoamyl alcohol mixture 
and after centrifugation precipitated with 3 volumes of RNAse free 100% ethanol. The 
pellet was washed with 75% ethanol and reverse-transcribed using standard techniques. 
The PCR products were confirmed to represent dJub cDNA by sequence analysis. dJub 
was amplified by PCR and cloned into pUAST+N-mCherry vector to construct UAS-
djub-mCherry and transgenic flies were generated as detailed above. To construct the 
HA-LIMD1 construct, human LIMD1 cDNA was cloned into HA-pUAST vector.  
 
Twin-spot analysis and gene expression studies.  
All mutant clones were induced using the FLP/FRT system (Xu and Rubin 1993). Clones 
in the eye were generated in flies/larvae of the following genotype: djub,FRT19a /Ubi-
GFP, FRT19a; eyeless-FLP and NeoFRT19a /Ubi-GFP, FRT19a; eyeless-FLP. Ubi-
GFP, FRT19a; eyeless-FLP (from N. Dyson).  For rescue experiments in the wing 
imaginal discs, clones were generated in flies of the following genotype: djub,FRT19a/ 
Ubx-FLP tub-GFP FRT19a;en-gal4/ UAS-djub-mcherry and NeoFRT19a/ Ubx-FLP tub-





Generation of djub EGUF/HID clones  
Eyes composed almost entirely of mutant tissue were generated by the EGUF/Hid 
method (Stowers and Schwarz 1999). djub mutant eyes were created in flies of the 
following genotype: FRT19A djub/GMR-hid, FRT19A, l(1)Cell Lethal1; eyeless-GAL4-
ey,UAS-FLP/+ and the control flies were of the genotype: NeoFRT19A/GMR-hid, 
FRT19A, l(1)Cell Lethal1; eyeless-GAL4,UAS-FLP/+. djub mutant eyes in which cell 
death was blocked by eye-specific expression of P35 were generated in flies of the 
genotype: FRT19A djub/GMR-hid, FRT19A, l(1)Cell Lethal1;eyeless-GAL4,UAS-
FLP/UAS-P35. For the genetic interaction studies, female fly eyes mutant for sav, wts, 
hpo and heterozygous for djub were of genotypes: FRT19A djub/+; FRT42D 
HpoKC202/FRT42D, GMR-hid, l(2)CL-R1; eyeless-GAL4,UAS-FLP/+,  FRT19A 
djub/+;eyeless-GAL4,UAS-FLP/+;FRT82B savshrp3/FRT82B GMR-hid, l(3)CL-R1 and 
FRT19A djub/+;eyeless-GAL4,UAS-FLP/+;FRT82B wtsp1/FRT82B GMR-hid, l(3)CL-R1. 
GMR-hid,FRT19A,l(1)CL1/FM7a;eyeless-GAL4,UAS-FLP,  FRT42D,GMR-hid,l(2)CL-
R1/Cyo; eyeless-GAL4,UAS-FLP,  eyeless-GAL4,UAS-FLP/Cyo;/FRT82B GMR-hid, 
l(3)CL-R1/TM2 and UAS-P35 (Bloomington Drosophila Stock Center). 
 
Generation of MARCM clones  
MARCM clones(Lee and Luo 1999) for the epistasis experiments were generated by heat 
shocking third instar larvae for 1 h at 37°C and dissecting female pupal eyes of the 
following genotypes 40 h APF : (a) hsFLP, tub-gal80, FRT19A/+; UAS-GFP, UAS-
lacZ/+; UAS-yki /tub-gal4 (b) djub, FRT19a/ hsFLP, tub-gal80, FRT19A; UAS-GFP, 
UAS-lacZ/+; UAS-yki/tub-gal4 (c) hsFLP, tub-gal80, FRT19A/+; UAS-hpoRNAi/UAS-
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GFP, UAS-lacZ; tub-gal4/dicer (d) djub, FRT19a/ hsFLP, tub-gal80, FRT19A; UAS-
hpoRNAi/UAS-GFP, UAS-lacZ; tub-gal4/dicer (e) hsFLP, tub-gal80, FRT19A/+; UAS-
GFP, UAS-lacZ/dicer; UAS-wtsRNAi/tub-gal4 and (f) djub, FRT19a/ hsFLP, tub-gal80, 
FRT19A; UAS-GFP, UAS-lacZ/dicer; UAS-wtsRNAi tub-gal4. UAS-yki (K. Irvine, 
Rutgers University), UAS-hpoRNAi (N. Tapon, Cancer Research UK) and UAS-wtsRNAi 
(Vienna Drosophila RNAi Center).  
 
GAL4/UAS analysis 
Gene over-expression and RNAi assays were carried out using the GAL4/UAS system 
(Brand and Perrimon 1993). GAL4 driver lines used: 1096-gal4, GMR-gal4, and 
engrailed-GAL4. UAS lines used: UAS-djub-mCherry, UAS-djubRNAi (22.5 and 18.1) 
and UAS-P35.  
 
Fly lines and staging of pupae 
All crosses took place at 25°C. Pupae were staged at 0hrs after puparium formation 
(APF) as white pre-pupae and maintained at 25°C. , Wandering third instar larvae were 
used for third instar imaginal disc dissections. 
 
Mounting of Adult wings, cell counting and statistics 
Adult flies were stored in 80% ethanol until ready for dissections. Only female flies were 
used for analyses. Wings were removed in 75% glycerol (in PBS) for mounting. 
Coverslips were sealed with nail polish. Wing cells were counted in the area bounded by 
the L4 and L5 veins and the second intervein, and the average and standard deviation 
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were plotted using Image J and Microsoft Excel. The Mann-Whitney U non-parametric 
test was used to calculate statistical significance of the number of cells, and the area of 
the wing region between various genotypes. 
 
Other fly strains  
DIAP1-LacZ and UAS-Ex flies were from G. Halder (University of Texas M. D. 
Anderson Cancer Center), Ft422 flies were from K. Harvey (Peter MacCallum Cancer 
Centre, Australia), INREx15 flies were from L. Pick (University of Maryland), Chico1 flies 
were from D.L Stern (Princeton University), Foxo25 flies were from E. Hafen (Institute of 
Molecular Systems Biology, Switzerland) and dmyc1 flies were from P. Gallant 
(Zoologisches Institut, Switzerland).  
 
Scanning Electron Microscopy  
Scanning electron microscopy (SEM) of adult flies was carried out as previously 
described (Cordero, Larson et al. 2007). Adult fly samples were dehydrated and sputter-
coated before being imaged using a Hitachi S-2600H scanning electron microscope 
(Department of Otolaryngology, Washington University in St Louis).  
 
Immunohistochemistry  
Pupal retina and eye and wing imaginal disc dissections were carried out in PBS 
following which the tissue was fixed in 4% paraformaldehyde dissolved in PBS. After 
fixation, tissues were washed in PBST (PBS + 0.5% Triton X-100) and incubated at 4°C 
overnight with primary antibody diluted in PAXDG buffer (0.1% BSA, 0.3% Triton X-
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100, 0.3% deoxycholate, 5% normal goat serum in PBS). Tissues were then washed 3 
times with PBST for 10 mins each, and incubated for 3 hrs at room temperature or 
overnight at 4°C with secondary antibody diluted in PAXDG (1:1000). Tissues were then 
rinsed with PBST and transferred onto slides for mounting in vectasheild mounting 
medium containing DAPI (Vector Labs).  Images were captured at room temperature on a 
LSM 510 Zeiss confocal microscope using 63x oil objective. Image J and Photoshop 
(Adobe) were used to process images. The following antibodies were used: rat α-DE-
cadherin (IC) (1:10, DSHB), rabbit α-dJub (1:400), mouse α-DIAP1 (1:200, B. Hay, 
California Institute of Technology), mouse α-BrdU (1:20, Becton-Dickinson), mouse α-
CyclinE (1:40, H. Richardson, Peter MacCallum Cancer Center, Australia), rabbit α-
Activated Caspase3 (1:100, Abcam) and mouse α-b-gal (1:2000, Promega). Secondary 
antibodies used were Alexa Fluor 488 and 568 (Invitrogen), rabbit α-HA (1:100, Abcam) 
and Cy5 (Jackson ImmunoResearch Laboratories). 
 
Immunoprecipitation 
HEK 293 T cells (4X105 plated in 12-well plates 24 hours prior to transfection) were 
transfected with the specified constructs. Drosophila S2 cells were cultured at room 
temperature in Express Five SFM media (Invitrogen) and 50 µg/mL 
penicillin/streptomycin were transiently transfected by using FuGene6. 48 hours after 
transfection, cells were harvested by washing with cold PBS, and lysed with 200ml of IP 
buffer (20 mM HEPES [pH 7.5], 120 mM NaCl, 5 mM NaF, 1 mM sodium 
orthovanadate, 0.5 mM EDTA, 1 mM DTT, 5% glycerol, 0.1% NP-40, and protease 
inhibitor cocktail from Sigma). Extracts were sonicated briefly, and then subjected to 
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centrifugation at 15,000xg for 15 min for clearing. 10ml of lysate was saved (mixed with 
20ml of SDS sample buffer) as 5% input.  For each IP (HEK 293T cells), the remaining 
cell lysate was mixed with 5 ml of IP buffer washed M2AG beads (1:1 [vol/vol], Sigma), 
for 1 hour at 4°C with gentle rotation. For S2 cells, lysates were precleared with protein 
G beads alone for 1 hr, then incubated overnight with 1mg of mouse α-myc antibody 
(Upstate), following which Protein G beads were then added for 1 hr.  The 
immunoprecipitates were then washed with 1ml of IP buffer 4 times and finally boiled in 
25 l SDS loading buffer. 8ml of boiled samples were run on SDS-PAGE under reducing 
condition and then transferred to nitrocellulose membranes for Immunoblot analysis.  
 
MDCK cell culture and transfection 
MDCK canine kidney cells were cultured in 1X MEM (Gibco) containing 10% FBS 
(Invitrogen) and 50 µg/mL penicillin/streptomycin. Nucleofections (Amaxa cell line 
Nucleofection Kit L) was used to transfect MDCK cells with siRNAi directed against 
Ajuba and LIMD1, according to the manufacturer’s instructions. Equal numbers of cells 
were immediately plated on three different sized dishes so as to have cells plated at low, 
medium and high densities. Forty-eight hours after nucleofection the cells were harvested 
for immunoblot analysis.   
 
Immunoblotting and Antisera used.  
Fly tissue, S2 cells or HEK 293T cells were lysed in RIPA buffer [150 mM NaCl, 10 mM 
Tris-HCl (pH 7.5), 1mM EDTA, 1% Triton-X100, 0.35% DOC, 0.25% NP-40, 
0.1%SDS], PMSF and protease inhibitor cocktail (Sigma). Lysates were then cleared by 
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centrifugation and boiled for 5 minutes in SDS sample buffer and resolved by 10% SDS-
PAGE, under reducing conditions. Proteins were transferred to nitrocellulose in transfer 
buffer (48mM Tris, 390mM, glycine, 0.1% SDS, 5% methanol) and immunoblots were 
probed with primary antibodies: rabbit α-dJub (1:1000), mouse α -Flag (1:10000, Sigma), 
rabbit α -YAP (1:1000, Cell Signaling), rabbit α-P-YAP(S127) (1:1000, Cell Signaling), 
mouse α-myc (0.1 g/ml, A. Shaw, Washington University St. Louis), rabbit α-Warts 
(1:1000, K. Irvine, Rutgers University), rabbit α-YFP (1:1000, Invitrogen), rabbit α- 
Ajuba (1:1000) (RAKESH K. GOYAL and ANTHONY J. MUSLIN) and rabbit α- 
LIMD1 (1:1000) (Feng, Zhao et al. 2007). For quantification, blots were minimally 
exposed and then scanned for quantification using ImageJ software.  
 
Djub Antibody Generation 
Rabbits were immunized with a dJub N-terminal peptide (TTQRTQTQARNPGNSDSDYETL) 
coupled to KLH. Polyclonal antiserum was affinity-purified using the immunizing peptide 









Figure 1. dJub regulates tissue size by controlling cell number. (A-C) Wings from 
females wt flies (A), female flies expressing dJub RNAi (B), or dJub-mCherry transgene 
(C). 1096-Gal4 was used to drive RNAi or transgene expression. (D) Outlines of the 
wings in panels A-C. (E, F) Quantification of relative wing areas (E) and cell numbers 
(F) of genotypes in A-C. Area and cell number measurements were taken from the wing 
region located between veins L4 and L5, and wt defined as 100% (N=20 for each). (G) 
Extracts of mammalian HEK293 cells transfected with myc-dJub immunoblotted with 
dJub antiserum (left) or Myc antiserum (right). (H) Immunoblot analysis of dJub protein 
levels in wt or dJub RNAi-expressing larval eye imaginal discs. Actin serves as loading 
control. Relative amount of dJub protein is indicated below each lane. Mid-pupal wt eyes 
(I) or dJub RNAi expressing eyes (J) stained for DE-cadherin.  Secondary (arrows) and 
tertiary (arrowheads) interommatidial cells are highlighted. Loss of interommatidial cells 
in dJub RNAi expressing pupal eyes denoted by arrows (J). (K) Quantification of relative 
numbers of interommatidial cells in wt versus dJub RNAi pupal eye. Interommatidial 
cells were counted in 20 fields, each containing a cluster of at least 7 ommatidia. (L-O) 
Mid-pupal wt eyes stained for DE-cadherin (L), dJub (M), and merged image (N). Z-
stack analysis of line in N is shown above panel N (N). (O) Immunostaining with dJub 
antiserum preabsorbed with immunizing peptide. (P-R) Scanning electron micrographs 
(SEMs) of female adult eyes. WT (Q), djubI generated via the EGUF-Hid method, which 
results in eyes composed almost entirely of mutant tissue (Q), and GMR-gal4 driven 
overexpression of UAS-dJub-mCherry transgene (R). (S-U) Female third-instar larval eye 
imaginal discs containing wt (S) or djubI mutant (T, U) clones marked by the absence of 
GFP expression (black). (U) Enlarged view of djubI and wt twin spot clones. Yellow 
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arrow identifies djubI clones, red arrow identifies wt twin spot clone containing two 
copies of Ubi-GFP, and white arrow identifies tissue carrying one copy of Ubi-GFP. In 
all experiments wings and eyes were dissected from female flies. In graphs data are 
shown as mean percentages +/- standard deviation, with N= 20 for each genotype. (***) 
Represents p-value < 0.001 and (*) represents p-value < 0.05. Anterior is to the left for all 























Figure 2. djub affects cell proliferation and apoptosis and affects expression of 
DIAP1 and Cyclin E. Wt (A, B) or djubI (A’, B’) Female larval eye imaginal discs, 
composed almost entirely of cells homozygous for either a lethal-free FRT19A 
chromosome (A, B), or an FRT19A chromosome carrying djub I deficiency (A’, B’).  (A, 
A’) Proliferation detected by BrdU incorporation (green). Cells anterior to the 
morphogenetic furrow (white arrowhead). Cells posterior to the furrow (yellow arrow). 
(B, B’) Apoptosis detected by an antibody specific for activated caspase 3. (C-E) Third-
instar larval eye imaginal discs containing djubI clones (GFP –ve, yellow arrows) stained 
for DIAP1 (C’), DIAP1-lacZ (D’), or Cyclin E (E’) expression. Anterior is to the left for 




















Figure 3. djub genetically interacts with the Hippo pathway. (A-H) Genetic interaction 
analyses. SEMs of adult female Drosophila eyes of wt and Hippo pathway mutants 
(A,C,E,G) and djubI  or Hippo pathway mutants containing a deletion of a single copy of 
djub (B,D,F,H), as indicated. Mid-pupal eye dissections of wt and Hippo pathway 
mutants at low and high magnifications (I, J, L, N and I’, J’, L’, N’ respectively) or 
Hippo pathway mutants containing a deletion of a single copy of djub (K, M, O and K’, 
M’ and O’), as indicated, and stained for DE-cadherin to identify interommatidial cells. 
Scale bars in (A-H) equal 100mm and (I-O) equal 10mm. (P) Quantification of 
interommatidial cell numbers in 10 random fields containing 10 ommatidia each of 
genotypes in A-H. Data are shown as mean percentages +/- standard deviation and (***) 



















Figure 4. djub is epistatic to hpo based on clonal area. (A-H) Genetic epistasis analysis.  
Female mid-pupal eyes stained for DE-cadherin (red).  Wt showing normal sized GFP 
positive wt MARCM clones (A).  (B) djubI MARCM clones (GFP +ve) are smaller than 
Wt. (C) MARCM clones overexpressing Yki (GFP +ve). (D) MARCM clones mutant for 
djubI and overexpressing Yki (GFP +ve). (E) MARCM clones expressing wts RNAi 
(GFP +ve). (F) MARCM clones mutant for djubI and expressing wts RNAi (GFP +ve). 
(G) MARCM clones expressing hpo RNAi (GFP +ve). (H) MARCM clones mutant for 
djubI and expressing hpo RNAi (GFP +ve). (I) Graphical representation of the clonal area 
(GFP +ve) for each genotype as a percentage of the entire pupal eye area.  In graphs data 
are shown as mean percentages +/- standard deviation, with N= 10 for each genotype. 



















Figure 5. djub is epistatic to hpo based on interommatidial cell number. (A-H) 
Genetic epistasis analysis.  Female mid-pupal eyes stained for DE-cadherin (red/white). 
Wt showing normal pattern of secondary and tertiary interommatidial cells and GFP 
positive wt MARCM clones (A, A’).  (B, B’) djubI MARCM clones (GFP +ve) showing 
a loss of interommatidial cells. (C, C’) MARCM clones overexpressing Yki (GFP +ve). 
(D, D’) MARCM clones mutant for djubI and overexpressing Yki (GFP +ve). (E, E’) 
MARCM clones expressing wts RNAi (GFP +ve). (F, F’) MARCM clones mutant for 
djubI and expressing wts RNAi (GFP +ve). (G, G’) MARCM clones expressing hpo 
RNAi (GFP +ve). (H, H’) MARCM clones mutant for djubI and expressing hpo RNAi 
(GFP +ve). Arrows identify changes in interommatidial cell numbers. (I) Graphical 
representation of the percent increase of interommatidial cells within the clonal area 
(GFP +ve) as compared to wild type (set at 100% IOCs) for each genotype.  In graphs 
data are shown as mean percentages +/- standard deviation, with N= 10 for each 
















Figure 6. Ajuba LIM proteins associate with components of the Hippo pathway in 
mammalian cells and influence YAP phosphorylation. (A-D) HEK293 cells were co-
transfected with LIMD1-YFP (A), Ajuba-YFP (B), Myc-WTIP (C), or Myc-Zyxin (D) 
and Flag-tagged Mst1, Lats1/2, WW45 or YAP, as indicated.  Cell lysates were 
immunoprecipitated for each Hippo pathway member (anti-Flag), and bound products 
Immunoblotted (IB) for the presence of each LIM protein (anti-YFP or anti-Myc).  
Immunoblots of input controls (5%) are shown on the right side of each panel.  
(E) HEK293 cells were transfected with the indicated member of the Hippo pathway in 
the absence or presence of LIMD1-YFP.  Levels of phospho-S127-YAP (upper panel) or 
total YAP (lower panels) were then determined by immunoblot (IB) analysis. Relative 
amounts of phospho-S127-YAP with respect to total YAP protein is indicated below each 
lane. (F) MDCK cells were transfected with control Luc siRNA (lanes 1-3) or Ajuba and 
LIMD1 siRNAs (lanes 4-6) and then plated at low (LD), medium (MD) and high density 
(HD). Amount of S127-YAP phosphorylation relative to total YAP for each density 
within control and Ajuba/LIMD1 depleted cells was determined by immunoblotting. The 
relative level of YAP phosphorylation for each density between control and 
Ajuba/LIMD1 depleted cells was determined and is indicated above the lanes. (G) 
Working model, based upon results herein, for how Ajuba LIM proteins could influence 














 Supplemental Figure 1. dJub is the Drosophila ortholog of the Ajuba sub-family of 
mammalian LIM domain-containing proteins and dJub regulation of wing size is 
evolutionarily conserved. (A) Schematic of the human and drosophila members of the 
Ajuba and Zyxin sub-families of LIM proteins. Orange circles denote LIM domains in 
each protein. LIM domain homology is listed to the right. Red lines above indicate the 
regions in dJub targeted by two RNAi hairpin constructs (22.5 and 18.1). Adult fly wings 
from wt (B, E), dJub RNAi 22.5 (C, F), dJub RNAi plus dJub-mCherry rescue transgene 
(D), and dJub RNAi plus human HA-LIMD1 rescue transgene (G) flies. In all cases 
1096-GAL4 was used to drive transgenes specifically in the wing. (H) Quantification of 
wing area relative to wt wings. Data are shown as mean percentages +/- standard 
deviation, with N= 20 for each genotype. (***) Represents p-value < 0.001 and (*) 
represents p-value < 0.05. (I) Immunolocalization of human HA-LIMD1 transgene in 
larval wing imaginal discs. DE-cadherin staining (I, red), HA-LIMD1 staining (I’, green), 
























Supplemental Figure 2. Generation of djub deficiency alleles and rescue of djub null 
phenotype. (A) Schematic of the genomic region containing djub, including the location 
of the FRT-bearing P elements (black/grey triangles) used to generate the djub 
deficiencies. A1 through C2 refer to PCR primers used to verify the presence of each 
FRT-mediated deletion. (B) Genomic PCR confirmation of deficiencies. Due to the size 
of intervening genomic DNA, primer pairs A1-A2 and B1-B2 fail to amplify a PCR 
product unless the desired deletion has occurred. Primer Pairs C1-C2 amplify a product 
only if the desired deletion has not occurred. (C) Immunoblot blot (IB) analysis of dJub 
protein levels in cell lysates prepared from larval eye imaginal discs from wt or 
heterozygous djubI flies.  Actin serves as loading control, and the relative amount of dJub 
protein is listed below each lane. (D-F) Third-instar larval wing imaginal discs containing 
wt clones (GFP -ve) (D), or djubI mutant clones (GFP -ve) (E and E’) expressed 
throughout the wing discs using Ubx-flp. dJub-mCherry transgene (red) was expressed 
only in the posterior compartment of the wing using en-gal4 (E or E’). djubI mutant + 
dJub-mCherry clones in the posterior compartment (red arrows E’), anterior compartment 
djubI mutant only clones (yellow arrows E’). (F) Quantification of the relative area 
occupied by wt clones (from D), posterior compartment djubI mutant clones co-
expressing djub-mCherry (from E), and anterior compartment djubI mutant clones (from 
E) calculated as percent area occupied by GFP-negative clones relative to total tissue area 










Supplemental Figure 3. Loss of dJub function does not affect neuronal differentiation 
or adherens junctions organization. Loss of function Hippo pathway mutants do not 
affect dJub localization. (A) Larval eye imaginal disc containing djubI mutant clones 
(GFP negative), generated by Eyeless-flp, and stained for the neuronal marker ELAV. 
White arrows indicate ELAV-positive photoreceptors. (B) SEM of djubI mutant adult eye 
(EGUF-Hid method). (C) SEM of djubI mutant eyes also expressing the anti-apoptotic 
factor P35 in all eye cells via GMR-GAL4.  (D, D’) Third-instar larval eye imaginal discs 
containing djubI mutant clones marked by the absence of GFP expression (black) stained 
for DE-cadherin (red in D, white in D’). (D”) Enlarged view of djubI mutant clones; 
white arrow identifies normal DE-cadherin staining in djubI mutant clones. (E-G) Mid-
pupal eyes from wtsx1 (E), hpo (F), and savshrp3 (G) loss of function mutants stained for 


















Supplemental Figure 4. DJub genetically interacts with the Hippo pathway but not 
the Insulin Receptor Pathway or Myc (A-J) Wings from adult wt flies (A, F), dJub 
RNAi-expressing flies (B, G), or expressing dJub RNAi in a background heterozygous 
for wtsX1 (C) or ykiB5 (H). (D and I) Schematics of the outline of  wings shown in (A-C) 
and (F-H), respectively. (E, J) Quantification of the relative wing areas for the indicated 
genotypes. 1096-GAL4 was used for wing-specific expression of UAS-dJub RNAi. (K) 
Table summarizing whether enhancement or suppression of the fat eye and of the djub 
RNAi small wing phenotype occurred for the indicated genotypes (i.e., genetic 
interaction). Hippo pathway (Wts, Yki, Ex, Fat), Insulin Receptor pathway (INR, Chico, 
FOXO), and Myc. (L) S2 cells co-transfected with dJub-myc and Hpo-Flag, Sav-HA and 
Yki-HA and Wts, as indicated.  Cell lysates were immunoprecipitated for dJub (anti-
Myc), and bound products Immunoblotted (IB) for the presence of each Hippo pathway 
member.  Immunoblots of input controls (5%) are shown on the left side of each panel. 
Data are shown as mean percentages +/- standard deviation, with n=20 for each genotype. 
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A junctional role for the dJub and the Hippo pathway members in Drosophila 
Studies carried out in this thesis as well as previous studies from the lab have 
shown that the Ajuba LIM proteins are highly expressed in epithelial cells, interact with 
α-catenin, and localize specifically to adherens junctions (Figure 1). This has been shown 
to be true in both mammalian and Drosophila epithelial cells. In chapter 2, I show that 
Ajuba LIM proteins appear to regulate the kinetics of nascent junction formation by 
delaying the establishment of functional Adherens and Tight junctions, and in chapter 3 
we establish a novel tissue-growth regulatory role for the Ajuba LIM proteins. So, the 
question remains if there is a link between the junctional and growth control roles of the 
Ajuba LIM proteins.  
Interestingly, in Drosophila, mutations in a number of genes (scribbled, discs 
large, lethal giant larvae) have been show to disrupt cell polarity and also induce 
overproliferation (Bilder, Li et al. 2000; Bilder and Perrimon 2000; Bilder 2004). Zygotic 
mutations in several of the Drosophila junctional proteins lead to a “giant larva” 
phenotype, the result of excessive growth and proliferation. Importantly, the epithelia in 
these mutants are not composed of the typical flat columnar cells, but rather a mass of 
rounded, poorly adhesive cells that sit on top of each other. These results suggest that a 
mutation in a single gene can, in fact, simultaneously induce junctional and growth 
defects, and also that these two mechanisms are under similar genetic control.  
Based on these results, we decided to investigate how Ajuba functions to both 
stabilize junctions as well as to promote growth. Of note, unlike the genes previously 
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described (scrib, dlg, lgl) that are at junctions and induce overproliferation when 
perturbed, Ajuba LIM proteins have the opposite phenotype. That is, loss of function 
mutations in Ajuba LIM proteins in Drosophila leads to tissue atrophy. One possible 
mechanism by which the Ajuba LIM proteins carry out this dual function, junctional 
stability and growth promotion, is that the loss of stable junctions when the LIM proteins 
are depleted may lead to growth defects by leading to the activation of the Hippo 
pathway and therefore increased in cell death and decreased cell proliferation and/or by 
inappropriately triggering the poorly understood mechanisms of contact inhibition. 
Another possibility is that the Ajuba LIM proteins have other undiscovered interacting 
partners and co-ordinate different polarity and growth control pathways.  
We have shown in Chapter 3 that the Ajuba LIM proteins directly interact with 
the Hippo pathway to negatively regulate the pathway’s growth regulatory role. The 
Hippo pathway plays a critical role in regulating organ size by transcriptionally 
regulating growth and apoptosis genes. Mutations in the upstream members of the 
pathway induce massive hyperplastic overgrowth phenotypes of epithelial tissue (hpo, 
wts, sav). The upstream regulators of the Hippo pathway namely Fat, Expanded and 
Merlin all localize to the Sub-Apical Region (Figure 1), and thus may be involved in 
relaying information about cell density and organ size to the downstream elements of the 
Hippo Pathway. Whether or not, and how, these upstream members and/or the Ajuba 
LIM proteins are capable of linking signals from cell junctions to the level growth 
regulation is yet to be determined.  
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Recent studies have shown that wts is capable of enhancing the dlg phenotype in 
Drosophila ovaries (Zhao, Szafranski et al. 2008). These data are exciting since it 
provides a possibility of cross-talk between the Scrib/Lgl/Dlg pathway at the Sub-Apical 
region in Drosophila and the Hippo growth control pathway. However, in this study the 
upstream members of the Hippo pathway namely, Ft, Ex and Mer did not enhance the dlg 
mutant phenotype, suggesting that multiple signals may converge at the level of Wts. 
Whether the Ajuba LIM proteins are the connection from junctions to Wts is not known.  
The investigations in Chapter 3 were conducted in larval eye and wing tissue where dJub 
did not seem to affect cell junctions in any obvious manner. In this chapter we further 
analyzed the epithelial junctional role of dJub in Drosophila at other developmental 
stages namely, the embryo and in the pupal eye. We also analyzed Hippo pathway 
mutants to see if they also give rise to defects in cell junctions in addition to giving rise to 
the overproliferation phenotype.  
The Ajuba LIM proteins and the Hippo pathway in the context of cell density and 
contact inhibition 
 The phenomenon of “contact inhibition” is a hallmark of cells growing in culture, 
where normal cells stop proliferating upon achieving confluency. Cancer cells, typically, 
have lost contact inhibition, and thus continue to grow even after reaching their final 
tissue size. However, the phenomenon of contact inhibition is still poorly understood. 
Recent studies have shown that components of the Hippo pathway may regulate contact 
inhibition. For instance, as cell density increases and cells become confluent, Mer 
becomes dephosphorylated and activated, which has been shown to be necessary and 
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sufficient to mediate contact inhibition and the cessation of proliferation (Shaw, 
McClatchey et al. 1998; Morrison, Sherman et al. 2001). In further support of a role for 
the Hippo pathway in mediating contact inhibition Lats (Wts) and WW45 (Sav) null 
mouse embryonic fibroblasts display a loss of contact inhibition as well. And finally, 
YAP is phosphorylated and translocates to the cytoplasm upon but not prior to cells 
achieving confluence (Zhao, Wei et al. 2007). In fact, the ACHN cancer cell line, which 
has a WW45 mutation and therefore activated YAP, does not respond to contact 
inhibition, instead, these cell continue to proliferate even after confluency is reached.  
However, the introduction of dominant negative form of YAP restores the ability of these 
cells to undergo contact inhibition (Zhao, Wei et al. 2007). Based on the data, a possible 
model is that when cells in culture reach confluence, cell-cell interactions trigger 
signaling events that lead to the activation of the Hippo pathway. The Hippo pathway 
mediates the downregulation of the pro-growth and anti-apoptotic genes sends the “stop 
proliferation” signal leading to contact inhibition. Identification of the upstream signal, 
and the method by which the pathway senses confluency is still a mystery. The results in 
this Chapter describe a possible role of the Ajuba LIM proteins in a cell density 











djub is essential for organization of epithelia in the Drosophila embryo  
 
 My work on the function of Ajuba LIM proteins in mammalian cell culture showed 
that epithelial cells require Ajuba LIM proteins to form nascent, stable, and functional 
adherens and tight junctions in a timely manner. However, the existence of the three 
Ajuba subfamily proteins, and the likelihood of functional redundancy between them 
made it difficult to assay the phenotype of simultaneously deleting all three via siRNA. 
Having established the fly system (Chapter 3), as an appropriate mode to assess the effect 
of removing Ajuba family function, we decided to investigate the role of djub in the 
Drosophila embryonic epidermis. The Drosophila embryonic epidermis provides a good 
model system for both genetic analysis as well as the establishment of epithelial polarity 
in vivo. During the process of Drosophila embryonic development, a fully functional 
epithelium forms, and it contains separate apical and basolateral compartments. Adherens 
junctions are the first junctional complex to form post cellularization, and these junctions 
gradually mature to form zonula adherens belts around the apex of the cells (Figure 1). 
This is the region to which the cadherin/catenin complexes localize. Also, unlike MDCKs 
or other cells in vertebrates, these cells do not have Tight junctions, but rather Septate 
Junctions below the adherens junction (Figure 1). In addition, a Subapical Region 
develops which is important for the cells to polarize. The two main complexes that 
localize to this region are the Crumbs complex and the Bazooka complex, both are 
essential for cells to establish polarity. 
 To see if djub may play a role in he formation of cell-cell junctions, we first asked 
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if we can detect dJub in Drosophila embryos. We stained early to late stage embryos with 
dJub as well as DE-cadherin (Figure 2). We found that similar to the pupal eye in 
Drosophila and to MDCK cells, dJub colocalized with DE-cadherin in fly embryos 
(Figure 2A-B).   Next, we asked whether loss of djub function gives rise to a phenotype 
in Drosophila embryos. The removal of zygotic djub function did not yield any obvious 
embryonic phenotypes. However, djub is supplied maternally, thus we made germline 
clones that lack djub function and found that djub maternal clones yielded embryos with 
severe epidermis defects (Figure 2C). The phenotype of djub null embryos are 
reminiscent of mutations in genes like crumbs and bazooka, which are reqired to establish 
the initial apical-basal polarity of cells (Figure 2D-E). These data suggest that dJub may 
play a role in establishing the polarity of epithelial cells in embryos, either by affecting 
the localization or activity of other polarity complexes, or by directly stabilizing the 
junctions.  
 
Djub effects primary cells in Drosophila pupal eye 
 The above results suggest that djub governs the formation of cel-cell junctions in 
mammalian as well as Drosophila epithelial cells. Thus, we decided to take a closer look 
at the function of djub in epithelial cells at later stages of development. We have 
established that cell junctions remain normal in the absence of djub (Chapter 3) both in 
larvae as well as in the pupal eye, as opposed to in the fly embryos where junctions do 
not seem to form properly. The difference between these tissues is that cell junctions are 
already formed in larval tissue and must still form in embryos. However, a closer look 
inspection of the pupal eye phenotype of djub mutant cells revealed that, in addition to 
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the cell death phenotype, we also observe a change in the primary cell size (Figure 3). It 
appears that primary cells lacking djub are often smaller than their pair. It is unclear what 
role dJub may have in maintaining the size and shape of these primary cells. This effect 
also seems to be specific to primary ommatidial cells. One possibility is that djub is 
necessary for the normal function of the cadherin-catenin complex at Adherens junctions, 
where djub localizes. Studies show that in arm mutations in follicle cells, the cadherin-
catenin complex breaks down and disrupts the architecture of the apical domain causing 
the cells to loose their shape and size, but retain a monolayered epithelial arrangement 
(Tanentzapf, Smith et al. 2000). A similar effect is seen in the djub mutant pupal eyes, 
where only the primary cell size changes with no effect on the surrounding tissue 
architecture. Further experiments are necessary to understand the mechanisms behind 
maintenance of primary cells and exactly how dJub plays a part in this.     
 
The Hippo pathway induces apical expansion 
 In addition to excessive proliferation and decreased apoptosis, hpo or wts mutant 
cells also show morphological defects consistent with perturbations to junctional 
complexes (Justice, Zilian et al. 1995; Xu, Wang et al. 1995; Wu, Huang et al. 2003). In 
fact previous studies have shown that clones that are homozygous null for wts produce 
abnormal bristles, and the mutant cells themselves show apical hypertrophy (Justice, 
Zilian et al. 1995), which in most ways is the opposite of the djub phenotype. During our 
analyses, we also made cull or overexpression clones for the Hippo pathway components. 
As expected, wts, hpo null clones and clones over expressing yki all had an 
overproliferation phenotype. However we noticed that in addition to the 
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overproliferation, the clones or cells marked with GFP, had an additional apical 
expansion phenotype (Figure 4A, B and C).  In each image the blue or red arrows point at 
secondary interommadial cells that show apical expansion as compared to the wild-type 
secondary cell marked by the yellow arrows. The apical expansion was seen in primary, 
secondary and tertiary interommatidial cells. This was different from the djub pupal eye 
phenotype, which only seemed to affect the primary ineterommatidial cells. Recent 
studies have shown that in the wing imaginal disc epithelium in clones deficient for 
Hippo pathway components, there is an increase in the expression levels of apical 
polarity proteins like aPKC, Crb and DE-cadherin which belong to the Bazooka and 
Crumbs polarity complexes (Genevet, Polesello et al. 2009; Hamaratoglu, Gajewski et al. 
2009). Both in our results as well as these studies, basolateral marker Dlg is not affected. 
These studies also show that the accumulation of the apical proteins was not necessary 
for the Hippo overgrowth phenotype, suggesting that the polarity genes do not in fact 
contribute to the Hippo signaling based overproliferation phenotype. Thus the apical 
expansion as well as the hypertrophy may be a separate non-growth control function of 
the Hippo pathway. It may be that djub and the Hippo pathway have opposite phenotype 
in the context of apical expansion and may, in fact, functionally interact here as well, but 
further experiments are required to confirm this.   
 
Ajuba LIM proteins and YAP localization correlate with Hippo activity in a cell 
density dependent manner 
 The data from Chapter 3 show that the Ajuba LIM proteins inhibit the Hippo 
pathway in the context of epithelial cells. We know from Chapter 2 that Ajuba LIM 
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proteins are important for the formation of nascent epithelial cell junctions. We next 
asked if there was a developmental context for this inhibition or if the Ajuba and Hippo 
pathway interaction along with Ajuba’s role at cell junctions contributed to contact 
inhibition. The Hippo pathway transcriptional coactivator, YAP has been shown 
previously to localize in a cell density dependent manner. We confirmed this 
phenomenon in PDV mouse epithelial cells. In low cell density, YAP predominantly 
localized in the nuclei of the cells. In contrast, YAP translocated to the cytoplasm at high 
density (Figure 5A and B). As described in previous work. We know that under 
conditions of high density, the Hippo pathway turns on and this leads to the 
phosphorylation of YAP by Lats, which in turn directs YAP to the cytoplasm, where it is 
sequestered.  
To examine for a possible role of djub in this process, we carried out the same 
experiment and assayed whether Ajub exhibits any cell density dependent function in its 
subcellular localization. At low cell densities, Ajuba localized mostly to the cytoplasm 
with almost no colocalization with E-cadherin (stains cell-cell junctions). However, at 
high densities, Ajuba localizes almost entirely to cell-cell junctions and completely 
colocalizes with E-cadherin (Figure 5C and D). These results were very intriguing as they 
again a tight functional link between the Hippo pathway and the Ajuba LIM proteins. For 
example, under conditions of low density, Ajuba may bind to Lats and in the cytoplasm 
and therefore inhibit Lats from phosphorylating YAP allowing cell proliferation to 
proceed. However at high densities, Ajuba LIM proteins may be recruited to the cell 
membrane by other means and this change in its subcellular localization may either free 
Lats to phosphorylate and inhibit YAP.  
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Ajuba LIM proteins and E-cadherin expression is related to cell density 
 Ajuba and LIMD1 proteins accumulate to higher levels in epithelial cells than in 
fibroblast cells. And, from Figure 5, we see that Ajuba localizes to distinct subcellular 
compartments in non-confluent vs confluent cells. Thus we hypothesize that Ajuba 
becomes stabilized once it localizes to Adherens junctions. Junctional proteins such as β-
catenin have been shown to be expressed at higher levels and sequestered at junctions 
under conditions of high confluency in HaCaT human keratinocytes.  Thus, we tested if 
Ajuba expression levels are altered as a result of cell density. We found that Ajuba is 
stabilized as a result of increasing cell density in multiple epithelial cell lines, namely 
PDV mouse cells as well as MDCK canine cells (Figure 6 A and C). Also, we found that 
LIMD1, like to Ajuba, also stabilized with increase in cell density in culture (Figure 6B). 
Interestingly we see a similar stabilization of E-cadherin with increased density of cell 
with equal actin loading (Figure 6 A-C). In addition to increased levels of both LIMD1 
and Ajuba LIM proteins in these cell, we also noticed a mobility shift. It appeared that 
with increase in cell density the mobility of Ajuba on the gel increases, suggesting the 
presence of some form of modification (Figure 6A). However, we have not yet been able 
to establish the molecular nature of this modification, though phosphorylation is an 
obvious possibility. Ajuba may undergo a post-translational modification as a result of 
increased cellular junctions. Other studies have shown that Ajuba is capable of being 
phosphorylated (Hirota, Kunitoku et al. 2003; Haraguchi, Ohsugi et al. 2007). In many 
instances a phosphorylation modification of a protein, will strengthen or weaken 
interactions with other proteins. Further studies are necessary to establish if in fact the 
mobility shift is due to the phosphorylation of Ajuba, whether the phosphorylation is cell 
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density dependent, and the effect the absence or presence of the phosphorylation on 













































Our experiments on cell density dependent localization, and possibly 
modification, link general cellular events to the modification and function of Ajuba 
proteins (Figure 5). For example the negative regulatory role of the LIM protein may, in 
fact, depend on the localization of the Ajuba LIM proteins to junctions. Ajuba’s 
cytoplasmic as well as membrane localizations may both be necessary for its growth 
enhancing function. Based on these and previous experiments we think that Ajuba LIM 
proteins may play a critical role as scaffolding proteins that provide a regulated link 
between membrane proteins and the cytoskeleton and participate in signal transduction 
pathways. We are presently carrying out experiments where we will ask if mutant forms 
of the Ajuba LIM proteins that are either always tethered to the membrane via a CAAX 
motif or are unable to localize to junctions, effect the role of the Ajuba LIM proteins in 
tissue growth control.    
We also observe that Ajuba and LIMD1 as well as E-cadherin seem to be 
stabilized at junctions. It appears that in low density cells or if the junctions are 
downregulated, Ajuba fails to be recruited or comes off the junctions. Other than the 
levels of the Ajuba LIM proteins we also observed that the Ajuba LIM proteins are 
modified in response to an increase in cell density. In denser cell cultures, Ajuba runs 
more slowly on the gel (Figure 6A) as compared to lower density cell cultures where 
Ajuba runs a little faster. Further investigations will clarify if the mobility shift is due to a 
phosphorylation modification or something else. Previous studies have shown that Ajuba 
can be phosphorylated, in one case GSK3β phosphorylates Ajuba to stabilize it and in 
another Ajuba is phosphorylated by Lats during mitosis and is important for spindle 
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formation (Abe, Ohsugi et al. 2006; Haraguchi, Ohsugi et al. 2007).  Further experiments 
are necessary to determine the other signals that appear to respond to cell density and 
modify Ajuba. Also how is Ajuba modified and what the effect of this modification is on 
Ajuba function, and interactions with other proteins.  
The fact Ajuba can localize to regions of cell-cell contacts indicates a role in 
direct intercellular communication. The Ajuba/djub loss-of-function studies in this thesis 
indicate that Ajuba may play a role in contact inhibition and in the formation of stable 
adherens junctions. Ajuba/djub colocalize with and associate with adherens junction 
components in wild type cells. We know that Ajuba interacts with α-catenin and actin. 
These and/or other undiscovered interactions with Ajuba may control the assembly and 
stabilization of mature adherens junctions.  The establishment of polarity, a crucial step 
for differentiation and morphogenesis may also depend on the function of djub/Ajuba 
proteins. In this way djub/Ajuba LIM proteins may also play a role in establishing or 
maintaining epithelial cell polarization. Thus by functioning to stabilize junctions in a 
density-dependent manner and establishing cell polarization the Ajuba LIM proteins/dJub 
might coordinate the control of cell-cell communication with cell proliferation in 
developing tissue.  
Interestingly although the Hippo pathway components lead to tissue overgrowth 
in various somatic tissue, unlike djub, germline clones of fat, expanded, hippo, sav and 
warts do not display any overgrowth of the mutant cells (Sun, Zhao et al. 2008). 
However, we do see a role for the Hippo pathway components at the pupal stage. From 
the data presented here and from other studies, it is clear that the Hippo pathway has an 
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effect on junctions. Whether this happens through the junctional members of the pathway 
like Ex, Mer or dJub or if in fact the apical expansion phenotype is a result of one or 
several polarity genes that are transcriptional targets of Yki is yet to be determined. It is 
possible that dJub and the Hippo pathway interact to maintain junctions as well. This 
interaction may be similar or distinct from the growth control interaction.  
The experiments in this chapter highlight the fact that the Ajuba LIM proteins as 
well as the Hippo pathway play a role in junctions and in return the junctions are 
important not only in the organization of epithelia but also in the regulation of tissue 
growth. The ability of the Ajuba LIM proteins to localize to junctions and also be 
involved in regulating the Hippo pathway suggests junctions might provide an ideal 
platform of communication between cells. Further the dual role of growth function and 
junction stabilization gives us a hint towards how junctional proteins integrate polarity 













Generation of MARCM clones  
MARCM clones(Lee and Luo 1999) for the Hippo pathway apical expansion 
experiments were generated by heat shocking third instar larvae for 1 h at 37°C 
and dissecting pupal eyes of the different genotypes 40 h APF.   
 
Immunohistochemistry for pupal eyes  
Pupal retina dissections were carried out in PBS following which the tissue was fixed in 
4% paraformaldehyde dissolved in PBS. After fixation, tissues were washed in PBST 
(PBS + 0.5% Triton X-100) and incubated at 4°C overnight with primary antibody 
diluted in PAXDG buffer (0.1% BSA, 0.3% Triton X-100, 0.3% deoxycholate, 5% 
normal goat serum in PBS). Tissues were then washed 3 times with PBST for 10 mins 
each, and incubated for 3 hrs at room temperature or overnight at 4°C with secondary 
antibody diluted in PAXDG (1:1000). Tissues were then rinsed with PBST and 
transferred onto slides for mounting in vectasheild mounting medium containing DAPI 
(Vector Labs).  Images were captured at room temperature on a LSM 510 Zeiss confocal 
microscope using 63x oil objective. Image J and Photoshop (Adobe) were used to process 
images. The following antibodies were used: rat α-DE-cadherin (IC) (1:10, DSHB).  
 
Generating X chromosome Germline Clones 
The first step was to generate females that are heterozygous for the djub deletion and the 
ovo D1 (Bloomington Stock number 23880) DFS chromosome by crossing ovo D1 males in 
the first cross (Cross 1). The djub females were balanced over FM6 and contained a FRT 
site on 19A (deletion distal to the FRT site). Recombination was induced between FRT 
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sites on these chromosomes by heat shock to drive the FLP recombinase. For the cross 
(Cross 1) about 30 virgin females (djub FRT19a/FM6) were crossed to 10-15 males 
(OvoD1-hsp70hsFLP FRT 19A/>) for 2 days of egg laying before being transferred to a 
new vial. Flies were flipped everyday after the first 2 days period, and then heat shocked 
for two consecutive days for 1.5 hrs in 37C water bath. For the next cross, non-FM6 
female virgin flies were collected that contained germlines with the homozygous djub 
mutation. These female flies were crossed to FM7-GFP males and the non-GFP embryos 
laid were djub null germline clones.  
 
Collection of Germline clone embryos 
Embryos were collected on a hard agar media made with grape juice, supplemented with 
some yeast paste after the agar has solidified. The females are more likely to lay their 
eggs on the yeast paste.  
 
Immunohistochemistry for Drosophila embryos  
Embryos were collected from grape caps placed underneath bottles containing the cross 
to generate the desired genotype. Collections were made overnight (0–16 h) and all day 
(0–8 h). Once embryos were collected, dead flies were removed with dissecting forceps. 
The embryos were then transferred into glass vials covered in mesh on one side and open 
on the other. Using a soft bristle brush and water, embryos were removed from the grape 
cap and transferred into the glass vials to dislodge the yeast paste.  The yeast paste was 
completely removed using the brush and water running into the vial and flowing out the 
mesh where the embryos collected. The chorion layer of the embryos were removed by 
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placing the collection vial into a small beaker with a 50% bleach solution an incubated 
for 3–5 min. During the incubation, the embryos were gently swirled in the collection 
vials and rinsed with the bleach solution using a pasteur pipet. After this the embryos 
were washed extensively to remove the bleach. For the antibody staining, embryos were 





















Figure 1: Organization of Drosophila epithelium. The proteins of the Baz and Cbs 
complexes localize to the Subapical region (green), apical to the Adherens junctions 
(blue). Scrib, Dlg and Lgl form a complex basally to the Adherens junctions (red). Some 
regulators of growth and proliferation signaling pathways, such as EGFR, Fat, Expanded, 







Figure 2: djub germline clones have severe epithelial defects. (A-B) Wild-type 
Drosophila embryos stained for dJub (Green) and DE-cadherin (Red) at early stages of 
embryonic development (A-A’’) and towards the end of embryonic development (B-B’’). 
djub germline clone without dJub staining, stained for DE-cadherin in red. (D-D’) 
Crb11A22 mutant embryo TEM image (D) and stained for Nrx (D’). BazXi zygotic 







Figure 3: djub mutant pupal eyes display primary cell defects. Mid-pupal eye 
containing djub null mutant clones (GFP negative) expressed throughout the pupal eye 
using Eyeless-FLP and stained for DE-cadherin (red/white). Blue or red arrows point at 
primary cells that are mutant for djub or GFP negative. The white versus the red astrix 
(*), show a comparison of the pair of primary cells. The primary cells marked by red 







Figure 4: Apical expansion in Hippo pathway mutant cells. Mid-pupal eyes stained for 
DE-cadherin (red/white). GFP positive hpo null MARCM clones (A-A’); GFP positive 
wts null MARCM clones (B-B’); MARCM clones overexpressing Yki (GFP positive) (C-
C’). Arrows identify apical expansion. Blue and red arrows in each genotype point at the 
same cell that mutant for hpo or wts or overexpressing Yki. The yellow arrows point at 








Figure 5: YAP and Ajuba localization change with respect to cell density. (Top two 
panels) YAP nuclear versus cytoplasmic localization is cell density dependent. PDV cells 
were cultured sparsely (Row 1) or to confluence (Row 2). YAP was stained with anti-
YAP antibody (green). (Bottom two panels) Ajuba Cytoplasmic versus junctional 
localization is affected by cell density. PDV cells were cultured sparsely (Row 3) or to 
confluence (Row 4). Ajuba was stained with anti-Ajuba antibody (green). Cell outlines 









Figure 6: Ajuba LIM proteins and E-cadherin expression levels are regulated by cell 
density.  (A-C) Cell lysates from PDV mouse epithelial cells immunoblotted for Ajuba 
The black arrow points at the Ajuba band in low density cells and the red arrow shows 
the shift in Ajuba at higher densities as compared to the lower density (A). Cell lysates 
from PDV mouse epithelial cells immunoblotted for E-cadherin, LIMD1 and actin (B) 
and MDCK cells immunoblotted for E-cadherin Ajuba and Actin (C). PDV and MDCK 
epithelial cells were plated at increasing densities and then western blotted for the 
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The Ajuba family of LIM domain containing proteins localize to cell-cell or cell  
matrix adhesion sites in epithelia and fibroblasts, respectively, and can influence the 
stability of cell adhesive complexes. Some LIM proteins can also shuttle to and from the 
nucleus giving them the potential to coordinate cell surface adhesive signals with nuclear 
responses (Goyal, Lin et al. 1999; Kanungo, Pratt et al. 2000; Langer, Feng et al. 2008). 
Compared to the Zyxin sub-family members, the Ajuba subfamily of LIM proteins are 
highly expressed in organs abundant in epithelia, like skin, kidney, liver etc. Previous 
studies have shown that Ajuba interacts with a-catenin at the cadherin adhesive 
complexes, and this interaction is required for efficient recruitment of Ajuba to cell-cell 
junctions. Ajuba also directly interacts with F-actin via its PreLIM domain (Marie, Pratt 
et al. 2003). However, to what extent Ajuba proteins act as a bridge to stabilize the 
cadherin adhesive complexes, and/or contribute to the stability, formation, and function 
of nascent junctions remains unclear. Furthermore, since three Ajuba subfamily members 
exist in mammals, Ajuba, LIMD1 and WTIP, functional redundancy greatly complicates 
the ability to dissect the functional roles of the proteins. Thus, creating a system where 
one can assay the Ajuba family null phenotype- as I have done during my thesis research- 
should accelerate the ability to shed light on novel roles of these proteins.  
 
Ajuba LIM proteins in epithelia 
 
Here, I have established that the Ajuba LIM proteins play a role in the 
establishment of epithelial cell-cell junctions. We show that Ajuba LIM proteins 
influence de novo assembly of tight junctions and adherens junctions, maintain stable 
cell-cell junctions, and are necessary for the establishment of epithelia polarity. More 
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importantly, we show that Ajuba and LIMD1 each display similar junctional phenotypes, 
which worsen when the function of both LIMD1 and Ajuba are depleted. To overcome 
the issue of functional redundancy, which has hampered precise and systematic 
investigation of Ajuba proteins in mammalian systems, I generated null mutations of the 
only member of the Ajuba family in flies, djub. I found that djub is an essential gene that 
when specifically depleted in the eye or wing epithelium inhibits growth by increasing 
apoptosis and decreasing proliferation simultaneously. Through the investigations carried 
out in this thesis, I observed genetic and biochemical evidence that dJub negatively 
regulates the Hippo pathway by activating Wts (Lats1/2) kinase. We also find that in both 
Drosophila S2 cells, as well as in mammalian cells, Ajuba, LIMD1, and WTIP associate 
specifically with Lats and WW45 to influence YAP phosphorylation in cells. Thus, as is 
observed with the function of the Hippo signaling  pathway, these results suggest that the 
functional link between Ajuba proteins and the Hippo signaling pathway is also 
conserved from flies to humans.  
 
Subcellular compartment-dependent regulation of the Hippo pathway by the Ajuba 
LIM proteins  
 
My genetic and biochemical data (Chapter 3, Figure. 6) suggest that dJub 
influences the Hpo pathway by affecting Wts activity. Future experiments will focus on 
determining the molecular basis for Ajuba-mediated inhibition of Lats/Wts activity as 
well as the subcellular localization of this interaction. The possible modes by which 
Ajuba LIM proteins inhibit the activation of Lats/Wts is by inhibiting upstream kinases 
MST/Hpo from accessing and/or activating Lats/Wts, inhibiting the ability of Lats/Wts to 
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phosphorylate YAP/Yki, or affecting the subcellular localization of Lats/Wts or 
WW45/Sav and thus their access to the Hippo pathway. The other possibility is that the 
regulatory relationship between Ajuba LIM proteins (dJub) and Lats/Wts may not be 
simply unidirectional as Lats has been shown to phosphorylate Ajuba (Abe, Ohsugi et al. 
2006).  With respect to the subcellular localization of this interaction, accumulated 
studies of mammalian Ajuba LIM proteins have indicated that they function as adapter 
proteins (Langer, Feng et al. 2008) in multiple subcellular compartments, namely, 
adherens junctions, (Marie, Pratt et al. 2003), cytosol (Feng, Zhao et al. 2007), and the 
nucleus (Langer, Feng et al. 2008). Thus, the next question is, do the Ajuba LIM proteins 
need to be available in a specific compartment for their interaction and inhibition of the 
Hippo pathway. Future experiments will include using different constructs of LIMD1 (or 
Ajuba, dJub) where the proteins are either nuclear only, unable to translocate to the 
nucleus or tethered to the membrane using CAAX to check if the LIM proteins can still 
functionally regulate the Hippo pathway by measuring the phosphorylation state of Yap 
or Yki or if they can rescue the in vivo djub phenotype.  
 
Upstream regulation of the Hippo pathway 
One important factor that still remains unknown is what cellular or molecular 
signal initiates the activation of the Hippo signaling pathway. While my thesis work has 
added additional players, and complexity to the Hippo signaling pathway, this 
fundamental question still remains unanswered. The Hippo pathway upstream members 
Expanded (Ex) and Merlin (Mer), both FERM domain-containing proteins localize to the 
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plasma membrane and act in parallel to regulate Hpo. Also, upstream member Ft acts 
through modulating levels of Wts, by affecting Wts stability (Cho, Feng et al. 2006). We 
have shown that dJub, like its mammalian orthologs, localizes to cell-cell junctions in 
Drosophila epithelia (Chapter 3, Figure1L-O). Therefore, Ajuba LIM proteins may be an 
additional mode of regulation of the Hippo pathway besides the atypical cadherin Fat and 
Ex/Mer. There still remains the possibility that dJub influences the Hippo pathway higher 
up in the signaling cascade, at the level of Fat, Ex and Mer. Ajuba/dJub may act in 
conjunction with Mer and Ex or parallel to Hpo and lastly there is also the possibility of 
cross talk between these pathways all of which are as of yet undetermined.  Ajuba/dJub 
may also influence the pathway indirectly by regulating the levels or localizations of 
these proteins. It is also worth mentioning that although dJub localizes to junctions, the 
staining appears to be punctate. We have yet to determine the significance of the non-
uniform staining pattern. Thus, the regulation may not be linear, but occur via more 
complicated scenarios where the regulation of the Hippo pathway occurs downstream of 
Fat or in between Ex/Mer and Hippo. 
Recent studies have described new findings that suggest an apical polarity 
complex regulation role for Hpo independent of the pathway’s growth control function 
(Maitra, Kulikauskas et al. 2006; Genevet, Polesello et al. 2009; Hamaratoglu, Gajewski 
et al. 2009).  This finding and also the data from Chapter 4 that describe the apical 
junctional phenotype for mutants of the Hippo pathway members further provides 
evidence for the possibility of dJub having a junctional role with respect to the Hpo 
pathway. Whether the Ajuba LIM proteins are capable of directly interacting with Fat, or 
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whether the Ajuba LIM proteins link Ex or Mer to Hpo or whether this role is played by 
some other component is yet to be determined. 
 
Universality of the Hippo pathway  
Another aspect of the Hippo pathway that needs further investigation is in what 
cell types does the Hippo pathway normally function to regulate apoptosis and cell 
proliferation. In case of Drosophila the pathway as well as dJub are expressed and 
function to restrict growth in imaginal discs, which are essentially columnar epithelia. So 
the question arises if the pathway modulates size of tissue or tumor formation only in a 
subset of cell types or human tissues that are similar to Drosophila imaginal discs in their 
properties of growth, proliferation and apoptosis. As far as the Ajuba LIM proteins go, 
they are most highly expressed in epithelial tissue in mammals (RAKESH K. GOYAL 
and ANTHONY J. MUSLIN). With respect to the Hippo pathway, interestingly there are 
multiple types of tumors that develop spontaneously in NF2 mice, which include bone 
tumors and malignant mesothelioma. However, in humans it is predominantly central 
nervous system tumors that develop as a result of NF2 deficiency (McClatchey and 
Giovannini 2005). Lats1 deficient mice will develop soft tissue sarcomas and ovarian 
tumors but there are reports on these mice developing nervous system tumors or even 
mesothelioma (St John, Tao et al. 1999). Thus, the Hippo pathway seems to be consistent 
in its regulation in other non-epithelial tissues as well. However, to what extent are the 
Ajuba LIM proteins expressed in these tissues and whether they continue to inhibit the 
Hippo pathway is not known.  
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Hippo signaling and the Ajuba LIM proteins role in cell adhesion and contact 
inhibition 
We have established that Ajuba LIM proteins have a clear role in the overall 
morphology as well as stability and formation of epithelial cells. The depletion of Ajuba 
LIM proteins results in defects in stability or formation of epithelial sheets as well as cell-
cell adhesion of MDCK and PDV cells in suspension (Chapter 2, Figure 10). We show in 
Chapter 4, components of the Hippo pathway namely, Hpo, Wts and Yki induce 
aberrations in epithelial cell morphology. These results are intriguing as they raise the 
possibility that the Hippo pathway may respond to adhesion or cell-cell contacts between 
cells. In the Hippo pathway, mutations in several components lead to a distinctly rounded 
morphology of the mutant clone, indicative of altered cell adhesion (Nolo, Morrison et al. 
2006; Thompson and Cohen 2006). Furthermore, various mutations in the pathway 
appear to modify the adhesive properties of the cells in a way that the mutant cells 
preferentially bind to cells of the same genotype instead of a neighboring wild type cell. 
NF2-null MEFs have weakened cell-cell adhesion and do not undergo contact inhibition 
(Lallemand, Curto et al. 2003). In case of the Hippo pathway it is still not clear if the 
adhesion phenotype is a result of massive overproliferation or if there are downstream 
targets of the Hippo pathway that directly control cell-cell adhesion. However, the fact 
that several Hippo pathway activity regulators, namely, Ajuba LIM proteins, which are 
involved cell-cell adhesion strengths, and other upstream members such as Fat, Ex and 
Mer, which connect the cytoskeleton with the extracellular matrix receptors such as 
CD44 (Bretscher, Edwards et al. 2002), suggests that the Hippo pathway may in fact 
respond to adhesion or cell-cell contacts between cells.   
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Contact Inhibition and the Hippo pathway 
 Although we know that the Hippo pathway responds to contact inhibition, it is 
unclear how this process is carried out. In cell culture, high cell density activates the 
Hippo pathway, resulting in YAP shuttling into the cytoplasm, suggesting a role of YAP 
and the Hippo pathway on contact inhibition (Zhao, Wei et al. 2007; Lei, Zhang et al. 
2008). In fact this is also seen in vivo, in the mouse embryo trophectoderm, YAP 
localizes to the nucleus in the outer peripheral cells, but toward the inner cell mass where 
the cell density is higher, YAP is phosphorylated by Hippo and localized to the 
cytoplasm (Nishioka, Inoue et al. 2009). These data suggest that the Hippo pathway and 
YAP may be able to receive signals from cell contacts and interpret these cues and 
accordingly activate different developmental pathways. Further investigation is necessary 
to define the molecular pathway that links the detection of cell density to Yki/YAP 
regulation.  It is also not clear how Yki/YAP gets into the nucleus when the Hippo 
pathway is turned off.  One mechanism for the nuclear translocation of Yki/YAP is 
through an interaction with target transcription factors such as scalloped as shown in 
Drosophila S2 cells with Yki (Goulev, Fauny et al. 2008; Wu, Liu et al. 2008), and with 
TEAD4 and YAP in mammalian cells. But in many cases, such as with Sd, the target 
transcription factor is only expressed in a small subset of tissue where as Yki/YAP 
functions in a much more ubiquitous manner. Thus it will be interesting to see if different 
transcription factors play a role in regulating the nuclear localization of Yki/YAP and the 
mechanism by which this happens.  
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The data described in Chapter 4 regarding the subcellular localization of the 
Ajuba LIM proteins with respect to cell density is intriguing. The Ajuba LIM proteins are 
predominantly cytoplasmic at low cell densities, but at higher cell densities, Ajuba 
localization shifts to the junctions. At this point the implications of this change in 
localization with respect to cell density is not fully understood. Future experiments are 
necessary to measure the presence of a density dependent regulation of the Hippo 
pathway by the Ajuba LIM proteins. It will be interesting to see if the Ajuba LIM 
proteins interact with Lats in a cell density dependent manner. Like the rest of the Hippo 
pathway components, Fat mutant cells also have the rounded morphology and can impact 
Yki localization. Future experiments may also identify the extent to which Fat is involved 
in this process. 
 
Mammalian roles of the Ajuba LIM proteins and the Hippo pathway  
The novel growth-promoting role of the Ajuba LIM proteins, and their ability to 
inhibit the Hippo pathway has raised many new questions. Although these findings have 
begun to answer some of the queries regarding organ size regulation, as well as the role 
of the Ajuba family in epithelia, the studies were mainly carried out in a Drosophila 
model system. Thus, while the mammalian orthologs of Hippo and dJub proteins interact 
physically, it remains unclear whether they also control organ size in mammals. 
However, the Hippo pathway or components of the Hippo pathway have been implicated 
in tumorigenesis in mammals, for example, NF2 or mer is a known tumor suppressor 
gene and mutations in NF2 mutations can lead to neurofibromatosis. These studies alone, 
do not establish a role for the Hippo pathway members in size regulation, since many 
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other processes other than the Hippo pathway’s size regulatory role can lead to 
tumorigeneis. Two complementary reasons for the absence of a clear demonstration of a 
size regulatory role of the Hippo pathway in mammals may be, the apparent genetic 
redundancy of specific Hippo components (eg. Lats1) resulting in knock-out mice that 
are either viable and lack any obvious overgrowth characteristics of the parallel 
Drosophila mutant (St John, Tao et al. 1999) or embryonic lethal making it difficult to 
assess the involvement in size regulation (eg. YAP) (McPherson, Tamblyn et al. 2004; 
Morin-Kensicki, Boone et al. 2006). Recent studies have begun characterizing the Hippo 
pathway in mammals, for instance transgenic models that overexpresses YAP specifically 
in the mouse liver gave rise to a Hippo regulated overgrowth phenotype (Dong, 
Feldmann et al. 2007).   
Analysis of in vivo function of mammalian Ajuba family members, also suffers 
from the problem of genetic redundancy. For example, mice singly mutant for Ajuba or 
LIMD1 or doubly mutant for Ajuba/LIMD1 appear grossly normal and do not display 
any overt defects. No mouse model yet exists WTIP. Therefore, knock out or transgenic 
models, which allow us to manipulate the Ajuba LIM proteins and Hippo pathway 
components in a spatially and temporally restricted manner, are necessary. This would 
allow us to get around issues of lethality and more importantly investigate the role of 
these proteins in a developmental context. Further, such models would also allow the 
analysis of the Hippo pathway/Ajuba proteins function in other cellular processes, such 
as the possible role of the Hippo pathway in dendrite morphogenesis as has been recorded 
in Drosophila (Emoto, Parrish et al. 2006). Further investigation of the roles of the Hippo 
pathway in the mammalian system will also provide a way to ask whether the functions 
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of the Hippo pathway and Ajuba family proteins also intersect during the process of 
tissue organ regeneration, where tissues such as the liver regenerate back to, but not 
beyond, a critical size (Michalopoulos and DeFrances 1997). Clearly, future work on the 
nexus between Hippo pathway and Ajuba proteins I mammals holds promise to reveal 
new genetic and molecular insights into clinically relevant fields such tumorigenesis and 
regeneration.    
Hippo and Beyond 
Mechanisms that coordinate both cell proliferation and cell death in flies and 
mammals are critical for the normal development and homeostasis of these organisms. 
The combination of the two processes is an important failsafe mechanism to inhibit 
inappropriate proliferation of somatic cells. In most cases, activation of an oncogene (eg. 
myc) or a mutation in a tumor suppressor, leads to unscheduled proliferation. This 
untimely proliferation in turn signals other pathways that counter the excessive 
proliferation by increased apoptosis. The Hippo pathway though is able to override this 
phenomenon since mutating the members of the pathway (Hpo, Wts, Sav, Mats) leads to 
increased cell proliferation accompanied by inhibition of cell death. The Hippo pathway’s 
ability to both inhibit cell proliferation and promote apoptosis simultaneously makes it a 
great candidate for a robust mechanism of swiftly stopping organ growth during 
development. The pathway acts as an on/off switch for growth, making it susceptible to 
single component perturbations leading to detrimental uncontrolled growth.  
It is important to note that the Hippo pathway is likely regulated at many nodes. 
In fact my thesis work suggests that Ajuba LIM proteins regulate Hippo signaling at the 
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level of Warts, whereas previous works have shown regulation of Hippo activity by 
Ex/Mer or by Fat.  Fat itself will also regulates the levels of Wts via a parallel pathway 
through Dachs. We also don’t know if there are players downstream of Ex/Mer that 
activate the pathway. Fat has been shown to regulate Ex, but the receptor upstream of 
Mer is yet to be identified. Finally, Chapter 4 suggests there may be still other players 
such as the junctional proteins Scrib/Dlg/Lgl, that cross-talk with the Hippo pathway.  
Given the diversity of phenotypes that arise as a result of mutations in the Hippo 
pathway in Drosophila and mammals, the biological effect of Hippo signaling may be 
context dependent. For instance, in addition to its nuclear coactivating role and regulation 
of growth genes CyclinE and DIAP1, Yap can also promote cell death by binding to P73 
(a p53 family member) in the nucleus (Strano, Munarriz et al. 2001; Strano, Monti et al. 
2005). The fact that YAP can carry out these opposing roles suggests that YAP probably 
binds and activates different transcriptional factors to regulate progrowth versus 
proapoptotic genes. This may depend on the specific upstream signaling or a 
posttranslational modification that affects the stability and/or localization of YAP. In flies 
the Hippo pathway plays a role in several types of processes namely, retinal cell 
patterning, dendrite morphogenesis, regulation of oocyte polarity and even salivary gland 
degeneration. The role of Hpo in the salivary gland is Yki independent and PI3K 
dependent. This suggests that in addition to Yki there must be other downstream effectors 
of the pathway. In Drosophila, oocyte polarity by which the posterior follicle cell fate 
identity is determined during oogenesis is Fat in independent, suggesting there are other 
upstream effectors that can regulate the Hippo pathway.  Thus, the Hippo pathway is far 
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more complex than a direct linear regulatory mechanism of organ growth control. Future 
experiments will broaden our knowledge help us reconcile many of these findings. 
In summary, the work described in this thesis shows that the Ajuba LIM proteins 
have a novel and crucial role in epithelial cells in regulating the overall size of an organ. 
The Ajuba LIM proteins mediate the effect by acting as direct negative regulators of the 
Hippo growth regulatory pathway. They play an influential role in both Drosphila as well 
as mammals to regulate the transcriptional output of the pathway by impacting the 
phosphorylated levels of Yki (or Yap in mammals) and thereby the transcriptional levels 
of growth-regulating and apoptotic genes. It will be important, in the future, to 
understand the precise mechanism by which djub or Ajuba/LIMD1/WTIP regulate the 
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